Michael D. Murray, PharmD, MPH April 25, 2012 - Purdue University

PERSONAL INFORMATION 

EDUCATION 

MICHAEL D. MURRAY 

Distinguished Professor of Pharmacy and Endowed Chair of Medication Safety 

Purdue University, and 

Executive Director, Regenstrief Center for Healthcare Improvement and Research 

Regenstrief Institute, Inc. 

1050 Wishard Blvd., RG6 

Indianapolis, IN 46202 

Office: (317) 630-6482 

Fax: (317) 630-6611 

mmurray@regenstrief.org 

Home 

12975 MacAlister Trace 

Carmel, Indiana 46033 

Research Interests 

Improving medication use and safety in people with chronic diseases 

Factors affecting patient adherence to their chronic medications 

Pharmacoepidemiology of chronically administered medications 

Pharmacy services research in ambulatory settings 

Health care utilization of low-income minority people with chronic diseases 

Degrees: 

07/1991 - 08/1992 Master of Public Health, Indiana University, Bloomington, IN 

08/1976 - 08/1977 Doctor of Pharmacy, Duquesne University, Pittsburgh, PA 

05/1971 - 05/1975 B.Sc. Pharmacy, Duquesne University, Pittsburgh, PA 

Residency & Fellowship: 

08/1986 - 08/1988 Fellowship in Pharmacoepidemiology; Regenstrief Institute for Health 

Care; Indianapolis, IN 

08/1975 - 0719/77 Graduate Courses in Administration and Therapeutics; Philadelphia 

College of Pharmacy and Science, Philadelphia, PA 

06/1976 - 07/1977 Residency in Hospital Pharmacy; Thomas Jefferson University Hospital; 

Philadelphia, PA 

Other Training: 

1995 – 2009 SAS Institute, Cary, NC USA 

10/1995 Health Economics Workshop, McMaster University, Hamilton, Ontario, 

Canada (Faculty: Michael F. Drummond, Bernard O'Brien, George 

Torrance) 

07/1994 14th Annual New England Epidemiology Institute Summer Program, 

Epidemiology Resources Inc.; Tufts University, Boston 

03/1994 S-Plus Introductory & Advanced Workshops, Chicago 

07/1992 12th Annual New England Epidemiology Institute Summer Program, 

Epidemiology Resources Inc.; Tufts University, Boston 

Michael D. Murray, PharmD, MPH 1 

April 25, 2012

Professional Pharmacy Licensure: Indiana No. 26091748A, Pennsylvania No. RP-028755-L 

PROFESSIONAL EXPERIENCE 

2010 – present Investigator, Regenstrief Institute, Inc., Indianapolis, Indiana (William M. Tierney, 

MD, President and CEO) 

2010 – present Executive Director, Regenstrief Center for Healthcare Effectiveness Research, 

Indianapolis, Indiana (William M. Tierney, MD, President and CEO) 

2010 – present Distinguished Professor and Endowed Chair of Medication Safety, Department of 

Pharmacy Practice, College of Pharmacy, Purdue University (Steven Abel, 

PharmD, Chair; Craig Svensson, PharmD, PhD, Dean) 

2010 – present Co-director, Center for Medication Safety Advancement, Purdue University 

2010 – present Faculty Associate, Purdue University Center on Aging and the Life Course 

(Kenneth Ferraro, PhD, Director) 

2010 – present Adjunct Professor of Medicine, Department of General Internal Medicine and 

Geriatrics, Indiana University School of Medicine, appointed July 7, 2010. 

2005 – 2010 Research Fellow, Cecil G. Sheps Center for Health Services Research, 

University of North Carolina at Chapel Hill, appointed September 6, 2005 

(Timothy Carey, MD, Director) 

2004 – 2010 Mescal S. Ferguson Distinguished Professor and Chair, Division of 

Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University 

of North Carolina at Chapel Hill, appointed July 1, 2004 (Robert A. Blouin, 

PharmD, Dean) 

2004 – 2010 Affiliate Scientist, Regenstrief Institute, Inc. (Thomas Inui, MD, MSc, President & 

CEO, Clement McDonald, MD, Director) 

2004 – 2008 Director, Center for Pharmaceutical Outcomes & Policy, University of North 

Carolina at Chapel Hill, appointed July 1, 2004 

2004 – 2005 Adjunct Professor of Pharmacy, Purdue University School of Pharmacy 

1998 – 2005 Affiliate Scientist, Indiana University Center for Aging Research, (Christopher 

Callahan, MD, Director) 

2001 – 2005 Adjunct Professor of Medicine, Indiana University School of Medicine 

2002 – 2004 Bucke Professor of Pharmacy, Purdue University School of Pharmacy 

2000 – 2004 Senior Scientist, Regenstrief Institute (Thomas Inui, MD, MSc, President & CEO, 

Clement McDonald, MD, Director) 

1998 – 2004 Faculty Associate, Purdue University Center on Aging and the Life Course, 

(Kenneth Ferraro, PhD, Director) 

1996 – 2004 Director, Regenstrief Health Data & Epidemiology Section, Regenstrief Institute 

1999 – 2002 Professor of Pharmacy, Purdue University School of Pharmacy 

1992 – 2001 Adjunct Associate Professor of Medicine, Indiana University School of Medicine 

1997 – 2000 Scientist, Regenstrief Institute for Health Care 

1994 – 2000 Member, Health Care Quality Assessment and Improvement Section, 

Regenstrief Institute for Health Care, Indianapolis (William M. Tierney, MD, 

Director) 

1988 – 1999 Associate Professor of Clinical Pharmacy with Tenure, Purdue University School 

of Pharmacy 

1997 – 1998 Planning Member, Collaborative on Improving Prescribing Practices, Institute for 

Healthcare Improvement, Boston (Jerry Avorn, MD, Chair, Charles Kilo, MD, 

Coordinator, Donald Berwick, MD, Director) 

1996 – 1998 Research Director, Indiana Drug Evaluation and Analysis (IDEA) Center, 

Indianapolis (William M. Tierney, MD, Director) 



1994 – 1998 Faculty, HSR&D, Richard Roudebush VA Medical Center, Indianapolis (Morris 

Weinberger, PhD, Director) 

1988 – 1997 Faculty, Clinical Pharmacology Division, Indiana University School of Medicine, 

Indianapolis (D. Craig Brater, MD, Director) 

1982 – 1988 Assistant Professor of Clinical Pharmacy, Purdue University School of Pharmacy 

1977 – 1988 Clinical Coordinator, Department of Pharmacy Services, Wishard Memorial 

Hospital, Indianapolis 

1977 – 1982 Adjunct Assistant Professor of Clinical Pharmacy, Purdue University School of 

Pharmacy 

1976 Laboratory Assistant in Physical Pharmacy, Duquesne University 

1975 Laboratory Assistant in Biopharmaceutics, Duquesne University 

1975-1976 St. Clair Memorial Hospital, Pittsburgh; Staff Pharmacist 

1975 Thrift Drug Company, Indiana, Pennsylvania; Retail Pharmacist 

1974 McNeil Laboratories, Fort Washington, Pennsylvania; National Pharmaceutical 

Council Industrial Intern 

1973 Torrance State Hospital, Torrance, Pennsylvania; Extern 

HONORS 

Academic: 

2010 Distinguished Professor of Pharmacy, Purdue University 

2010 Endowed Chair of Medication Safety, Purdue University 

2004 Mescal S. Ferguson Distinguished Professor, University of North Carolina at 

Chapel Hill 

2003 Fellow of the International Society for Pharmacoepidemiology (FISPE) 

2002 Bucke, Professor of Pharmacy, Purdue University 

1999 – 2004 Purdue University Faculty Scholar Award 

1996 Award for Excellence in Health Science Research, Indiana’s Premier Award in 

Health Services Research, Indiana Public Health Foundation, Inc. 

1975 President of Class, Valedictorian, Who's Who in American Colleges and 

Universities 

1974 Vice-President of Class; Rho Chi Pharmacy Honorary (Historian), Beta Pi Sigma 

(Secretary) 

Other Accomplishments: 

Who’s Who in the World; Who’s Who in America; Who’s Who in Medicine and Healthcare; Who’s Who in 

Science and Engineering (2002); Who’s Who in Finance and Industry (2003). 

PUBLICATIONS 

Book Chapters 

Roth MT, Murray MD. Polypharmacy: Management. In: Capezuti EA, Siegler EL, Mezey MD, eds. The 

Encyclopedia of Elder Care: The Comprehensive Resource on Geriatric and Social Care. 2nd ed. New 

York: Springer Publishing Company 2008; 639-641. 

Morris AB, Murray MD. “The landscape of botanical medicine utilization and safety” In: Francis Lam YW, 

Huang SM, Hall SD, eds. Herbal Supplements – Drug Interactions: Scientific and Regulatory 

Perspectives. 1st ed. Taylor & Francis Group, New York, NY 2006; 1-25. 



Murray MD. Pharmacoepidemiology and Pharmacovigilance. In Remington: The Science and Practice of 

Pharmacy, 21 st Edition, Troy DB ed., Lippincott Williams & Wilkins, Baltimore, MD 2012; (In press) 

Murray MD. Pharmacoepidemiology. In Remington: The Science and Practice of Pharmacy, 21 st Edition, 

Troy DB ed., Lippincott Williams & Wilkins, Baltimore, MD 2005; 108:1958-67. 

Murray MD. Pharmacoepidemiology. In Remington: The Science and Practice of Pharmacy, 20 th Edition, 

Gennaro AR, ed., Lippincott Williams & Wilkins, Baltimore, MD 2000; 116:1980-89. 

Murray MD Shojania KG. Unit-Dose Dispensing. In: Making Healthcare Safer: An Evidence-Based 

Compendium of Patient Safety Practices. Shojania KG, Duncan BW, McDonald KM, Wachter RM, eds. 

Technical report prepared by the UCSF-Stanford Evidence-based Practice Center for the Agency for 

Healthcare Research and Quality (Evidence Report/Technology Assessment No. 43, AHRQ Publication 

No. 01-E058; July 2001.Full report available at www.ahrq.gov or Publication’s Clearinghouse 

ahrqpubs@ahrq.gov) 

Murray MD. Automated Drug Dispensing. In: Making Healthcare Safer: An Evidence-Based 

Compendium of Patient Safety Practices. Shojania KG, Duncan BW, McDonald KM, Wachter RM, eds. 

Technical report prepared by the UCSF-Stanford Evidence-based Practice Center for the Agency for 

Healthcare Research and Quality (Evidence Report/Technology Assessment No. 43, AHRQ Publication 

No. 01-E058; July 2001.Full report available at www.ahrq.gov or Publication’s Clearinghouse 

ahrqpubs@ahrq.gov) 

Murray MD. Polypharmacy: Management. In: The Encyclopedia of Elder Care: The Comprehensive 

Resource on Geriatric and Social Care. Mezey Mathy D., Bottrell Melissa M., Berkman Barbara J, 

Callahan Christopher M., Fulmer Terry T., Mitty Ethel L., Paveza Gregory J., Siegler Eugenia L., Strumpf 

Neville E, eds. New York: Springer Publishing Company 2001; 517-19 

Murray MD, Brater DC. Renal Effects of Ibuprofen. In: Ibuprofen: A Critical Bibliographic Review. Edited 

by K.D. Rainsford, Taylor & Francis Ltd London, 1999. 

Murray MD, Brater DC. Effects of NSAIDs on the Kidney, Progress in Drug Research, Edited by E. 

Jucker, Birkhäuser Verlag, Basel 1997; 49:155-71. 

Murray MD, Brater DC. Nonsteroidal Anti-Inflammatory Drugs. Clinics in Geriatric Medicine, Geriatric 

Clinical Pharmacology Edition 1990; 6:365-97. 

Murray MD, Brater DC. Renal Toxicity of the Nonsteroidal Anti-Inflammatory Drugs. Ann Rev Pharmacol 

Toxicol 1993; 32:435-65. 

Journal Articles 

Peer-reviewed 

Overhage JM, Gandhi TK, Hope C, Seger A, Murray MD, Orav J, Bates DW. Impact of Ambulatory 

Computerized Physician Order Entry on Preventable Adverse Drug Events. (Submitted) 

Aljadhey H, Adam M, Mayet A, Alshaikh M, Kalagi N, Altaweel I, Ahmed Y, Murray MD, Bates DW, 

Incidence of Adverse Drug Events in an Academic Hospital (Submitted) 

Campbell NL, Boustani MA, Skopeljia EN, Gao S, Unverzagt F, Murray MD. Medication Adherence in 

Older Adults with Cognitive Impairment: A Systematic Evidence Review. (Submitted) 



Noureldin M, Plake K, Morrow D, Tu W, Wu J, Murray MD. Effect of Health Literacy on Medication 

Adherence in Patients with Heart Failure. Pharmacotherapy (In press). 

Murray MD, The safety of H1N1 vaccine in Saudi children: a pharmacepidemiological study using 

modern technology in a developing country. Drug Safety (In press). 

Butler M, Farley J,Sleath B, Murray M, Maciejewski M. Medicare Part D Information Seeking: the Role of 

Recognition of Need and Patient Activation” for publication in Research in Social and Administrative 

Pharmacy. Research in Social and Administrative Pharmacy (In press). 

Chin J, Morrow DG, Stine-Morrow EAL, Conner-Garcia T, Graumlich JF, Murray MD. The Process- 

Knowledge Model of Health Literacy: Evidence from a Componential Analysis of Two Commonly Used 

Measures. Journal of Health Communication 2011 Oct; 16 Sup3:222-241. 

Patterson ME, Blalock SJ, Smith AJ, Murray MD. Associations Between Prescription Copayment Levels 

and β-Blocker Medication Adherence in Commercially Insured Heart Failure Patients 50 Years and Older. 

Clinical Therapeutics 2011 May; 33(5):608-16. 

Murray MD. Curricular considerations for pharmaceutical comparative effectiveness research. 

Pharmacoepidemiology and Drug Safety 2011 Jan; 20:797-804. 

Pressler SJ, Eckert GJ, Morrison WC, Murray MD, Oldridge NB. Evaluation of the Health Utility Index-3 in 

Heart Failure. J Card Failure 2011 Feb; 17(2):143-150. 

Murray MD, Harrison J. Prescription abandonment: another path to medication nonadherence. Ann Intern 

Med 2010 Nov; 153(10):680-681. 

Aljadhey H, Tu W, Hansen RA, Blalock S, Brater C, Murray MD. Risk of hyperkalemia associated with 

selective COX-2 inhibitors. Pharmacoepidemiology and Drug Safety 2010 Nov; 19:1194–98. 

Murray MD. Implementing pharmacy practice programs for the management of heart failure. Pharm 

World Sci 2010 Oct; 32(5):546-548. 

Roth AM, Ackermann RT, Downs SM, Downs AM, Zillich AJ, Holmes AM, Katz BP, Murray MD, Inui TS. 

The Structure and Content of Telephonic Scripts Used Effectively in the Indiana Medicaid Chronic 

Disease Management Program. Chronic Illness 2010 Jun; 6:83-88. 

Gandhi TK, Seger AC, Overhage JM, Murray MD, Hope C, Fiskio J, Teal E, Bates DW. Outpatient 

adverse drug events identified using electronic health record screening. J Patient Safety 2010 Jun; 

6(2):91-96. 

Sleath BL, Blalock SJ, Bender DE, Murray MD, Cerna A, Cohen MG. Latino patients' preferences for 

medication information and pharmacy services. J Am Pharm Assoc 2009; 49(5):632-6. 

Hansen RA, Dusetzina SB, Song L, Gaynes BN, Tu W, Murray MD. Depression affects adherence 

measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm 

Assoc 2009; (6):760-68. 

Sleath B, Blalock SJ, Bender D, Murray M, Cerna A, Cohen MG. Latinos' sources of medication and 

medication information in the United States and their home countries. Patient Educ Couns 2009; (2):279- 

82. 



Murray MD, Ritchey ME, Wu J, Tu W. Effect of a Pharmacist on Adverse Drug Events and Medication 

Errors in Outpatients with Cardiovascular Disease. Arch Intern Med 2009; 169(8):757-63. 

Hansen RA, Kim MM, Song L, Wanzhu T, Wu J, Murray MD. Comparison of methods to assess 

medication adherence and classify non-adherence. www.theannals.com, DOI 10.1345/aph.1L496 Ann 

Pharmacother 2009 Mar; 43(3):413-22. 

Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC. Factors associated with exacerbation of heart 

failure include treatment adherence and health literacy skills. Clin Pharmacol Ther 2009; 85(6):651-58. 

Hansen RA, Song L, Moore CG, Gilsenan AW, Kim MM, Calloway MO, Murray MD. Effect of ropinirole 

on sleep outcomes in patients with restless leg syndrome: meta-analysis of pooled individual patient data 

from randomized controlled trials. Pharmacotherapy 2009; 29(3):255-62. 

Hansen RA, Tu W, Li J, Wang J, Ambuehl R, McDonald CJ, Murray MD. Risk of adverse gastrointestinal 

events from inhaled steroids. Pharmacotherapy 2008; 28:1325-34. 

Levinthal BR, Morrow DG, Tu W, Wu J, Murray MD. Cognition and health literacy in patients with 

hypertension. J Gen Intern Med 2008; 23(8):1172-1176. 

Roswarski TE, Murray MD, Proctor RW. Framing, Patient Characteristics, and Treatment Selection in 

Medical Decision-Making. 3 rd Symposium of the Austrian Computer Society, University of Graz, Austria 

(Conference Proceedings) November 22, 2007 A. Holzinger (Ed.): USAB 2007, LNCS 4799, 318-325, 

©Springer-Verlag Berlin Heidelberg 2007. 

Morrow D, Clark, D, Tu W, Wu J. Young J, Weiner, M, Steinley D, Murray MD. Patients' experience with 

instructions: Influence preferences for heart failure medication instructions. J Aging Health 2007; 

19(4):575-593. 

Boustani M, Hall KS, Lane KA, Aljadhey H, Gao S, Unverzagt FW, Murray MD, Ognunniyi A, Hendrie HC. 

The association between histamine-2-receptor antagonists and cognition in African Americans. J Am 

Geriatr Soc 2007; 55(8):1248-53. 

Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus- 

Pizlo I, Weinberger M, Brater DC. Pharmacist intervention to improve medication adherence in heart 

failure: a randomized trial. Ann Intern Med 2007; 146(10):714-725. [This study was recognized by the 

Annals Editors as one of the year’s outstanding articles in health policy research. The Editors. Taking our 

vital signs: The year in review. Annals of Internal Medicine 2008; 149:58-59.] 

Morrow D, Clark, D, Tu W, Wu J. Young J, Weiner, M, Steinley D, Murray MD. Correlates of health 

literacy in older adults with chronic heart failure. Gerontologist 2006; 46:669-676. 

The USP Model Guidelines Expert Committee and US Pharmacopeia Staff. The U.S. Pharmacopeia and 

Model Guidelines for Medicare Part D Formularies. Ann Intern Med 2006; 145:448-453. 

Stroupe KT, Teal Y, Tu W, Weiner M, Murray MD. Association of refill adherence and healthcare use 

among adults with hypertension in an urban healthcare system. Pharmacotherapy 2006; 26:779-789. 

Morris AB, Li J, Kroenke K, Bruner T, Young JM, Murray MD. Factors associated with drug adherence 

and blood pressure in patients with hypertension. Pharmacotherapy 2006; 26:483-492. 



Rosenman MB, Holmes AM, Ackerman RT, Murray MD, Carney Doebbling, C, Katz BP, Li J, Zillich A, 

Prescott VM, Downs SM, Inui TS. The Indiana Chronic Disease Management Program. Milbank Quarterly 

2006; 84:135-63. 

Roswarski TE, Murray MD. Supervision of Students May Protect Academic Physicians from Cognitive 

Bias: A Study of Decision-Making and Multiple Treatment Alternatives in Medicine. Med Decis Making 

2006; 26:154-161. 

Bennett SJ, Welch JL, Eckert GJ, Oldridge NB, Murray MD. Nutrition in chronic heart failure with 

coexisting chronic kidney disease. J Cardiovasc Nurs 2006; 21(1):56-62. 

Seger A, Gandhi TK, Hope C, Overhage JM, Murray MD, Weber D, Fiskio J, Teal E, Bates DW. 

Development of a computerized adverse drug event (ADE) monitor in the outpatient setting. Advances in 

Patient Safety: Vol. 2: From Research to Implementation, Agency for Healthcare Research & Policy. 

2005; AHRQ 05-0021-2:173-183. 

Bennett SJ, Lane KA, Welch J, Perkins SM, Brater DC, Murray MD. Medication and dietary compliance 

beliefs in heart failure. West J Nurs Res 2005; 27(8):977-99. 

Li J, Rosenman MB, Holmes AM, Katz BP, Downs SM, Murray MD, Ackermann RT, Inui TS. Indiana 

chronic disease management program risk stratification analysis. Medical Care 2005; 43(10):979-984 

Morrow D, Weiner M, Deer M, Young J, Dunn S, McGuire P, Murray MD. Improving Medication 

Knowledge Among Older Adults with Heart Failure: A Patient-Centered Approach to Instruction Design. 

The Gerontologist 2005; 45(4):545-522. 

Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Nienaber N, 

McDonald CJ, Wolinsky FD. Can computer-generated evidence-based care suggestions enhance 

evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, 

controlled trial. Health Services Research 2005; 40(2):477-497. 

Subramanian U, Weiner M, Gradus-Pizlo I, Wu J, Tu W, Murray MD. Patient perceptions and provider 

assessment of severity of heart failure as predictors of hospitalization. Heart & Lung 2005; 34(2):89-98. 

Tu W, Morris AB, Li J, Wu J, Young J, Brater DC, Murray MD. Pharmacodynamics and Drug Action: 

Association between adherence measurements of metoprolol and health care utilization in older patients 

with heart failure. Clin Pharmacother & Therapeutics 2005; 77:189-201. 

Hope CJ, Wu J, Tu W, Young J, Murray MD. Barriers to adherence in elderly heart failure patients. Drug 

Information Journal 2004; 38:331-341. 

Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills 

with emergency department visits by adults 50 years or older with congestive heart failure. American 

Journal of Health-System Pharmacy 2004; 61:2043-9. 

Kroth PJ, McDonald CJ, Murray MD. Undertreatment of osteoporosis in women based on detection of 

vertebral compression on chest radiographs. American Journal of Geriatric Pharmacotherapy 2004; 

2:112-118. 

Huo N, Chui M, Eckert GJ, Oldridge NB, Murray MD, Bennett SJ. Relationship of age and sex to healthrelated 

quality of life in patients with heart failure. American Journal of Critical Care 2004; 13:153-161. 



Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with elevated liver enzymes are not 

at higher risk for statin hepatotoxicity. Gastroenterology 2004; 126:1287-1292. 

Murray MD, Young JM, Morrow DG, Weiner M, Tu W, Hoke SC, Clark DO, Stroupe KT, Wu J, Deer MM, 

Bruner-England TE, Sowinski KM, Smith FE, Oldridge NB, Gradus-Pizlo I, Murray LL, Brater DC, 

Weinberger M. Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly 

patients with chronic heart failure. American Journal of Geriatric Pharmacotherapy 2004; 2(1):53-65. 

Murray MD, Morrow DG, Weiner M, Clark DO, Tu W, Deer MM, Brater DC, Weinberger M. A conceptual 

framework to study medication adherence in older adults. American Journal of Geriatric 

Pharmacotherapy 2004; 2(1):36-43. 

Morrow D, Weiner M, Young J, Steinley D, Deer M, Murray M. Patient-centered instructions for 

medications prescribed for the treatment of heart failure. American Journal of Geriatric Pharmacotherapy 

2004; 2(1):44-52. 

Stroupe KT, Teal E, Weiner M, Gradus-Pizlo I, Murray MD. Health care and medication costs and use 

among older adults with heart failure. American Journal of Medicine 2004; 116:443-450. 

Tierney WM, Roesner JF, Seshadri, R, Lykens, MG, Murray, MD, Weinberger M. Assessing Symptoms 

and Peak Expiratory Flow Rate as Predictors of Asthma Exacerbations. J Gen Intern Med 2004; 19:237- 

242. 

Murray MD, Harris LE, Overhage M, Zhou XH, Eckert GJ, Smith FE, Nienaber-Buchanan N, Wolinsky 

FD, McDonald CJ, Tierney WM. Failure of Computerized Treatment Suggestions to Improve Health 

Outcomes of Outpatients with Uncomplicated Hypertension: Results of a Randomized Controlled Trial. 

Pharmacotherapy 2004; 24(3):324-337. 

Huang S-M, Hall SD, Watkins P, Serabjit-Singh C, Betz, JM, Hoffman, FA, Love L, Honig P, Coates PM, 

Bull J, Kearns GL, Murray MD. Drug interactions with herbal products & grapefruit juice: A Conference 

Report. Clinical Pharmacology & Therapeutics 2004; 75:1-12. 

Clark DO, Tu, W, Weiner M, Murray MD. Correlates of health-related quality of life among lower-income, 

urban adults with congestive heart failure. Heart Lung 2003; 32:391-401. 

Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Nienaber N, 

McDonald CJ, Wolinsky FD. Effects of computerized guidelines for managing heart disease in primary 

care: A randomized controlled trial. J Gen Intern Med 2003; 18:967-976 

Hope C, Overhage JM, Seger A, Teal E, Mills V, Fiskio J, Gandhi TK, Bates DW, Murray MD. A tiered 

approach is more cost effective than traditional pharmacist based review for classifying computer 

detected signals as adverse drug events. Journal of Biomedical Informatics 2003; 36:92-98. 

Murray MD, Callahan CM. Improving Medication Use for Older Adults: An Integrated Research Agenda. 

Ann Intern Med 2003; 139(5):425-429. 

Murray MD, Smith FE, Fox J, Teal EY, Kesterson JG, Stiffler TA, Ambuehl RJ, Wang J, Dibble M, Benge 

DO, Betley LJ, Tierney WM, McDonald CJ. Structure, functions, and activities of a research support 

informatics section. JAMIA 2003; 10:389-98. 

Bennett, SJ, Oldridge NB, Eckert GJ, Embree JL, Browning S, Hou N, Chui M, Deer M, Murray MD. 

Comparison of Quality of Life Measures in Heart Failure. Nursing Research July/August 2003; 52(4) 207- 

216. 



Chui M, Deer M, Bennett SJ, Tu W, Oury S, Brater DC, Murray MD. Association between Adherence to 

Diuretic therapy and Health Care Utilization in Heart Failure Patients. Pharmacotherapy 2003; 23(3):326- 

332. 

Brunt ME, Murray MD, Hui SL, Kesterson J, Perkins AJ, Tierney WM. Mass media release of medical 

research results: An analysis of antihypertensive drug prescribing in the aftermath of the calcium channel 

blocker scare of March 1995. J Gen Intern Med 2003; 18:84-94. 

Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, Seshadri R, Caffrey H, 

Roesner JF, Smith FA, Newell J, Collins JC, McDonald CJ, Tierney W. The Effectiveness of Pharmacist 

Care for Patients with Reactive Airways Disease: A Randomized, Controlled Trial. JAMA 2002; 288:1594- 

1602. 

Murray MD, Lane KA, Gao S, Evans RM, Unverzagt FW, Hall KS, Hendrie HC. Preservation of cognitive 

function with antihypertensive medications: A longitudinal analysis of a community-based sample of 

African-Americans. Archives of Internal Medicine 2002; 162:2090-2096. 

Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, Newell AJ, Collins J, Tierney 

WM. Issues in conducting randomized controlled trials of health services research interventions in nonacademic 

practice settings: The case of retail pharmacies. HSR: Health Services Research 2002; 

37:1067-1077. 

Lee M, Andritz MH, Curry CE, Kishi DT, Murray MD, Scott BE, Smith WE, Voght E, Flynn AA. Academic 

pharmacy’s role in practitioner preparation and continuing development to enhance healthcare and 

ensure optimal medication use. Report of the 2001-2002 Professional Affairs Committee. Am J Pharm 

Educ 2002; 66:23S-27S. 

Bennett, S.J., Oldridge, N.B., Eckert, G.J., Embree, J.L., Browning, S., Hou, N., Deer, M., & Murray, M.D. 

Discriminant properties of commonly used quality of life measures in heart failure. J Quality of Life 

Research 2002; 11:349-359. 

Bennett SJ, Perkins SM, Lane KA, Forthofer MA, Brater D, Murray MD. Social support and health-related 

quality of life in chronic heart failure patients. J Quality of Life Research 2001; 10:671-682. 

Amsler MR, Murray MD, Tierney WM, Brewer N, Harris LE, Marrero DG, Weinberger M. Pharmaceutical 

care in care pharmacies: Beliefs and attitudes of pharmacists and patients. J Am Pharm Assoc 2001; 

41(6):850-855. 

Murray MD, Deer MM, Ferguson JA, Dexter PR, Bennett SJ, Perkins SM, Smith FE, Lane KA, Adams 

LD, Tierney WM, Brater DC. Open-label randomized trial of torsemide compared with furosemide in 

patients with heart failure. Am J Med. 2001; 111:513-520. 

Bennett SJ, Perkins SM, Lane KA, Forthofer MA, Brater DC, Murray MD. Reliability and validity of the 

compliance belief scales among patients with heart failure. Heart and Lung 2001; 30:177-185. 

Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, Tierney WM. Pharmaceutical 

care program for patients with reactive airways disease. Am J Health-Syst Pharm 2001; 58:791-6. 

Barner JC, Mason HL, Murray MD. Use of an adapted precede model to identify factors influencing 

reported asthma self-management behaviors. J Social and Administrative Pharmacy 2000; 17:209-218. 



Richards SS, Emsley CL, Roberts J, Murray MD, Hall K, Gao S, Hendrie HC. The association between 

vascular risk factor mediating medications and cognition and dementia diagnosis in a community-based 

sample of African-Americans. J Amer Geriatr Soc 2000; 48:1035-41. 

Stroupe KT, Murray MD, Stump TE, Callahan CM. Association between medication supplies and 

healthcare costs in older adults from an urban healthcare system. J Am Geriatr Soc 2000; 48:760-768. 

Stroupe KT, Forthofer MM, Brater DC, Murray MD. Healthcare costs of patients with heart failure treated 

with torasemide or furosemide. Pharmacoeconomics 2000; 17:429-440. 

Perkins, SM, Tu W, Underhill MG, Zhou XH, Murray MD. The use of propensity scores in 

pharmacoepidemiologic research. Pharmacoepi Drug Safety 2000; 9:93-101. 

Murray MD. Information Technology: The infrastructure for improvements to the medication use process. 

Am J Health-Syst Pharm 2000; 57:565-71. 

Tu W, Perkins SM, Zhou XH, Murray MD. Testing treatment effect using propensity score stratification. 

Proceedings of the Section on Statistics in Epidemiology of the American Statistical Association 1999; 

105-107. 

Stroupe KT, Gaskins D, Murray MD. Health-care costs of inner-city patients with asthma. J Asthma 1999; 

36:645-655. 

Barner JC, Mason HL, Murray MD. Assessment of asthma patients’ willingness to pay for and give time 

to an asthma self-management program. Clin Ther 1999; 21:878-94. 

Murray MD, Loos B, Tu W, Eckert GJ, Zhou XH, Tierney WM. Work patterns of ambulatory care 

pharmacists with access to electronic guideline-based treatment suggestions. Am J Health-Syst Pharm 

1999; 56:225-32. 

Murray MD, Deardorff FW. Does managed care fuel pharmaceutical industry growth? 

Pharmacoeconomics 1998; 14:341-48. 

Murray MD, Loos B, Tu W, Eckert GJ, Zhou XH, Tierney WM. Effects of computer-based prescribing on 

pharmacist work patterns. J Am Med Inform Assoc 1998; 5:546-53. 

Murray MD. Tierney WM, Brater DC. Determining the effectiveness of torasemide and furosemide in 

heart failure: Design of a Randomized Comparison Using the Regenstrief Medical Record System. Clin 

Drug Invest 1998; 16:45-52. 

Murray MD, Lazaridis EN, Brizendine E, Haag K, Becker P, Brater DC. The effects of NSAIDs on 

electrolyte homeostasis and blood pressure in young and elderly patients with and without renal 

insufficiency. Amer J Med Sci 1997; 314:80-88. 

Tierney WM, Murray MD, Gaskins DL, Zhou XH. Using computer-based medical records to predict 

mortality risk for inner-city patients with reactive airways disease. J Am Med Inform Assoc 1997; 4:313- 

21. 

Murray MD, Haag KM, Black PK, Hall SD, Brater DC. Variable furosemide absorption and poor 

predictability of response in elderly patients. Pharmacother 1997; 17:98-106. 

Murray MD, Stang P, Tierney WM. Health care use by inner-city patients with asthma. J Clin Epidemiol 

1997; 50:167-74. 



Smith DM, Cox MR, Brizendine EJ, Hui SL, Freedman JA, Martin DK, Murray MD. An intervention on 

discharge polypharmacy. J Am Geriatr Soc 1996; 44:416-9. 

Murray MD, Black PK, Kuzmik DD, Haag KM, Manatunga AK, Mullin MA, Hall SD, Brater DC. Acute and 

chronic effects of nonsteroidal anti-inflammatory drugs on glomerular filtration rate in elderly patients. 

Amer J Med Sci 1995; 310:188-197. 

Tierney WM, Overhage JM, Takesue BY, Harris LE, Murray MD, Vargo DL, McDonald CJ. Computerizing 

guidelines to improve care and patient outcomes: The example of heart failure. J Am Med Inform Assoc 

1995; 2:316-22. 

Murray MD, Rupp MT, Overhage JM, Ebbeler DE, Main JW, Tierney WM. Multidimensional work 

sampling in an outpatient pharmacy. Pharmacy Practice Management Quarterly 1995; 15:44-56. 

Murray MD, Brater DC. Recommendations for the concurrent use of two or more NSAIDs. Drug Ther 

1994; 24:39. 

Murray MD, Birt JA, Manatunga AK, Darnell JC. Medication compliance in elderly outpatients using twicedaily 

dosing and unit-of-use packaging. Ann Pharmacother 1993; 27:616-21. 

Nappi J, Murray MD. Chair Report of the Task Force on Curricular Issues. 1991 Report to The American 

Association of Colleges of Pharmacy. Section of Teachers of Pharmacy Practice. Am J Pharm Educ 

1992; 56:202-8. 

Murray MD, Greene PK, Brater DC, Manatunga AK, Hall SD. Effects of flurbiprofen on renal function in 

patients with moderate renal insufficiency. Br J Clin Pharmacol 1992; 33(4):385-93. 

Murray MD, Brater DC, Tierney WM, Hui SL, McDonald CJ. Ibuprofen-associated renal impairment in a 

large general internal medicine practice. Am J Med Sci 1990; 299:222-229. 

Murray MD, Kohler RB, McCarthy MC, Main JW. Attitudes of house physicians concerning various 

antibiotic-use control programs. Am J Hosp Pharm 1988; 45:584-8. 

Murray MD, Kohler RB, Main JW. Effect of a targeted antibiotic advisory consult program on hospital 

antibiotic costs. Hosp Formul 1988; 23:518-30. 

Murray MD, Hancock BG, Main JW, Schechter BM. Conversion to Maxzide in a general medicine clinic. 

Hosp Formul 1988; 23:372-9. 

Murray MD, Darnell J, Weinberger M, Martz BL. Factors contributing to medication noncompliance in 

elderly public housing tenants. Drug Intel Clin Pharm 1986; 20:146-52. 

Darnell JC, Murray MD, Martz BL, Weinberger M. Medication use by ambulatory elderly: an in-home 

survey. J Am Geriat Soc 1986; 34:1-4. 

Murray MD, Brown BK. Theophylline-erythromycin interaction in an infant. Clin Pharm 1982; 1:107,111. 

Murray MD. Emetics and adsorbents in the first-aid treatment of toxic ingestions. Indiana Pharmacist 

1980; 61:172-78. 



Editorials & Commentary 

Peer-reviewed 

Murray MD, Harrison J. Prescription Abandonment: Another possible path to nonadherence. Annals of 

Internal Medicine 153:680-81. 

Murray MD. Pharmacists are the key to enhancing benefit risk for medicines [Commentary]. Arch Intern 

Med 2009, 169(18):1723. 

Murray MD Continuity of Health Care and the Pharmacist: Let's keep it simple. [Commentary]. Ann 

Pharmacother 2009; 43:745-47. 

Murray MD. Medication Instruction by Pharmacists: Making good on an offer. NC Med J 2007; 343-45. 

Weinberger M, Murray MD, Tierney WM. Pharmacist Care for Reactive Airway Disease [Letter] JAMA, 

2003; 289(9): 1105-1106. 

Murray MD, Kroenke K. Polypharmacy and Medication Adherence: Small Steps on a Long Road. J Gen 

Intern Med. 2001; 16: 137-139. 

Murray MD. Glucocorticoid use and risks of ocular hypertension and glaucoma [Letter]. JAMA. 1997; 

277: 1930. 

Murray MD. Medication Appropriateness Index: Putting a number on an old problem in older patients. 

[Editorial]. Ann Pharmacother 1997; 31: 643-44. 

Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatory drugs on renal function 

[Editorial]. Ann Intern Med. 1990; 112: 559-60. 

Consortia & Panel Reports 

Peer-reviewed 

Institute of Medicine, The Clinical Effectiveness Research Innovation Collaborative, National Academy of 

Sciences, Washington, DC, May 17, 2010. 

Expert Panel: Designing Pilot Programs to Distribute Patient Medication Information. Engelberg Center 

for Health Care Reform at Brookings Institution. 

Air Force Medical Service Health Services Data Warehouse Initiative Policy & Governance Committee, 

2011 

Planning Committee, Air Force Medical Service – Clinical and Translational Sciences Award 

Collaboration Symposium: Opportunities in Translational Science, Enabling New Research for Patient 

Centered Outcomes, Applied Informatics, and Pharmacoeconomics, May 13, 2011, National Institutes for 

Health Campus, Bethesda. 

CTSA, Comparative Effectiveness Research Key Function Committee, 2010 



Pediatric Medication Safety in the Emergency Setting: Current Challenges and Practical Solutions. 

Sponsored by the Health Resources and Services Administration, Maternal and Child Health Bureau, 

EMSC Program, (EMSC National Resource Center-contract no 240-03-0011) and Children’s National 

Medical Center in partnership with the American Academy of Pediatrics and the Duke University Health 

System, Duke University, Durham, NC. 

Simmons D, Phillips MS, Grissinger M, Becker SC and the USP Safe Medication Use Expert Panel. Erroravoidance 

recommendations for tubing misconnections when using Luer-tip connectors: A statement by 

the USP Safe Medication Use Expert Committee. Joint Commission Journal on Quality and Patient 

Safety. 2008; 34:293-96. 

Flynn B and the USP Safe Medication Use Expert Panel. Chapter 1066 Physical Environment That 

Promote Safe Medication Use. Pharmaceutical Forum 2008; 36:1549-58 

Medicare Model Guidelines Expert Panel, Model Guidelines. Centers for Medicare & Medicaid Services 

Cooperative Agreement No. 18-C-92305/3-01, United States Pharmacopeia Convention, Inc. 

www.usp.org 

Phillips MS, Williams RL and the USP Safe Medication Use Expert Panel. Improving the safety of 

neuromuscular blocking agents: A statement from the USP Safe Medication Use Expert Committee. Am J 

Health-Syst Pharm 2006; 63:139-42. 

Hicks RW, Becker SC, Cousins DD (2006). MEDMARX ® Data Report: a Chartbook of Medication Error 

Findings from the Perioperative Settings from 1998-2005. 

Santell JP, Hicks RW, Cousins DD (2005). MEDMARX ® Data Report: A Chartbook of 2000-2004 Findings 

from Intensive Care Units and Radiological Services. Rockville, MD: USP Center for the Advancement of 

Patient Safety. 

Hicks RW, Santell JP, Cousins DD, Williams RL (2004). MEDMARX SM 5 th Anniversary Data Report: A 

Chartbook of 2003 Findings and Trends 1999-2003; Rockville, MD: USP Center for the Advancement of 

Patient Safety. 

Non peer-reviewed publications 

Murray MD. 1991 Report on the International Society of Pharmacoepidemiology Membership Survey. 

PharmacoEpidemiology Newsletter. 1991; 5: 9-10. 

Murray MD. 1990 Report on the International Society of Pharmacoepidemiology Membership Survey. 

PharmacoEpidemiology Newsletter. 1990; 4: 5-6. 

Murray MD. Falls in the elderly as a result of medication use: Implications for the consultant pharmacist. 

Geriatric Pharmacy Newsletter. 1990; 3: 7-8. 

Murray MD. Considerations in planning for antibiotic control. Emerging Issues in Hospital Pharmacy. 

1987; 4: 1-6. 

Book Reviews 

Murray MD. Geriatric Dosage Handbook. 1st Edition, by Semla TP, Beizer JL, Higbee MD. Lexi-Comp, 

Inc., Hudson OH, 1993. Amer J Pharm Educ. 1994; 58:251. 



Murray MD. Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd Edition, by Sackett DL, 

Haynes RB, Guyatt GH, Tugwell P. Little, Brown, & Company, Boston, 1991. Clin Pharm 1993;12: 866- 

67. 

Murray MD. Pharmacoepidemiology: An introduction. 2nd Edition. Edited by A.G. Hartzema, M. S. Porta, 

and H.H. Tilson. Cincinnati, Harvey Whitney Books Company, 1991. In J Pharmacoepi. 1992; 2: 87-8. 

Software Review 

Murray MD. SlideWrite Plus for Windows, Advanced Graphics Software, Inc., Carlsbad, CA., Amer J 

Hosp Pharm. 1994; 51: 3002,3006. 

Abstracts 

Gao X, Bertel S, Chin J, Madison A, Morrow DG, Stine-Morrow EAL, McKeever S, Conner-Garcia T, 

Graumlich JF, Murray MD. The effects of domain knowledge and concept map on processing and 

memory of hypertension-related text, Health Literacy Annual Research Conference, National Academy of 

Sciences, Washington, DC. October 2011. 

Chin J, Morrow DG, Stine-Morrow, EAL, Gao X, Conner-Garcia T, Graumlich JF, Murray MD. The 

disassociation of effects of domain knowledge in processing general and health texts among older adults 

with hypertension. American Psychological Association Convention 2011. 

Authors: Jessie Chin, Daniel G. Morrow, Elizabeth A.L. Stine-Morrow, Xuefei Gao, Thembi Conner- 

Garcia, James F. Graumlich and Michael D. Murray 

Katz AJ, Morrow D, Tu W, Wu J, Murray MD. Effect of health literacy on adherence in heart failure 

patients. Pharmacoepid Drug Safety 2009; 18:S141-2. 

Chin J, D’Andrea L, Morrow D, Stine-Morrow E, Conner-Garcia T, Graumlich J, & Murray M (2009). 

Cognition and illness experience are associated with illness knowledge among older adults with 

hypertension. Proceedings of the Human Factors and Ergonomics Society 53rd Annual Meeting. Santa 

Monica: Human Factors & Ergonomics Society. San Antonio, TX. October 19-23, 2009. 

Burton MM, Hope CJ, Murray MD, Hui SL, Overhage JM. The cost of adverse drug events in 

ambulatory care. AMIA Annu Symp Proc. 2007 Oct; 11:90-93. 

Rosenman M, Holmes AM, Ackermann RT, Murray MD, Li J, Katz BP, Katz BP, Doebbeling CD, Zillich 

AJ, Prescott VM, Downs SM Inui TS. Evaluation of the Indiana Chronic Disease Management Program: 

Opportunities and challenges. American Public Health Association 133 rd Annual Meeting, November 7, 

2005. 

Tu W, Weiner M, Wu J, Murray MD. A pharmacy-based intervention reduces emergency-department 

visits in patients with hypertension. J Gen Intern Med 2005; 20(Sup 1):#13626, P60. 

Morris AB, Li J, Kroenke K, England T, Young J, Murray MD. Factors associated with medication 

adherence and blood pressure in hypertensive patients. J Gen Intern Med 2005; 20(Sup 1):#134194, 

P67. 

Weiner M, Tu W, Wu J, Ding Y, Murray MD. Failure to intensify antihypertensive therapy. J Gen Intern 

Med 2005; 20(Sup 1):#136186, P67. 



Morris A, Murray MD, Li JJ, Kroene K, Young J, Bruner-England T. Factors associated with medication 

adherence and blood pressure in hypertensive patients. SGIM 28 th Annual Meeting, Abstract accepted for 

presentation New Orleans May 13, 2005. 

Murray MD, Seger AC, Gandhi TK, Overhage M, Lamar V, Hope C, Bates DW. Use of computers to 

identify and prevent adverse drug events in outpatients. Medinfo 2004; 2004 (CD): 1766. 

Hsieh TC, Gandhi TK, Seger AC, Overhage JM, Murray MD, Hope C, Weber D, Chan B, Fiskio J, Sun Y, 

Chang FY, Lamar V, Bates DW. Identification of adverse drug events in the outpatient setting using a 

computerized, text searching monitor. Medinfo 2004; 2004 (CD):1651. 

Shah NR, Poon EG, Seger AC, Fiskio J, Murray MD, Overhage JM, Bates DW. Risk factors for outpatient 

adverse drug events. J Gen Intern Med 2004; 19:207. 

Murray MD, Wu J, Tu W, Clark DO, Weiner M, Morrow DG, Brater DC. Health literacy predicts 

medication adherence. American Society for Clinical Pharmacology and Therapeutics. 2004; 75(2) P 76. 

Tu W, Li J, Morris A, Wu J, Murray MD. Use of electronic adherence with PK parameters to predict 

outcomes of older adult heart failure patients. American Society for Clinical Pharmacology and 

Therapeutics. 2004; 75(2) P 76. 

Hope CJ, Wu J, Tu W, Murray MD. Ability of medication adherence, knowledge and skills to predict 

emergency department visits in older adults with heart failure. American Society for Clinical 

Pharmacology and Therapeutics. 2004; 75(2) P 76. 

Murray MD, Young J, Wu J, Tu W, Morrow DG, Clark D, Huffman M, Murray L, Weiner M. Effect of 

verbal comprehension on medication adherence. DIA 5 th Annual Workshop on Pharmaceutical Outcomes 

Research. Tucson, AZ. January 21-23, 2004. 

Shah NR, Poon EG, Seger AC, Fiskio J, Murray MD, Overhage JM, Bates DW, Gandhi TK. Risk Factors 

for Outpatient Adverse Drug Events. 27 th Annual Meeting SGIM. 

Bates DW, Gandhi TK, Seger A, Ladak-Merchant Z, Golden J, Overhage M, Murray MD. Development 

of a computerized adverse drug event (ADE) monitor in the outpatient setting using electronic medical 

record data. Advances in Patient Safety: From Research to Implementation. 

Murray MD, Wu J, Tu W, Boggs L, Clark D, Weiner M, Morrow D. Vision, reading, and health literacy as 

predictors of medication adherence. Pharmacotherapy 2003; 23(10) P 1356. 

Murray MD. Improving Drug Use in Patients with Hypertension. Proceedings from the Workshop on 

Cardiovascular Disease in Chronic Kidney Disease: Options for Intervention. P. 54. National Institute of 

Diabetes & Digestive & Kidney Diseases National Heart, Lung & Blood Institute. March 10-11, 2003, 

Crystal Gateway Marriott Arlington, Virginia. 

Adigun AQ, Chalasani NP, Murray MD, Ho H, Hall S. QTC Prolongation as a Risk Factor for Mortality in 

Liver Cirrhosis. Clinical Pharmacology & Therapeutics 2003; 73(2) P 34. Annual Meeting Wash DC 4/2- 

5/2003. 

Hope CJ, Seger AC, Overhage JM, Gandhi TK, Teal EY, Mills VL, Bates DW, Murray MD. Use of 

Electronic Medical Records to Detect Adverse Drug Events and Medication Errors in Outpatients. . 

Clinical Pharmacology & Therapeutics 2003; 73(2) P 96. Annual Meeting Wash DC 4/2-5/2003. 



Morrison GC, Oldridge NB, Eckert GJ, Murray MD, Bennett SJ. A Comparison of Methods for Assessing 

Health Related Quality of Life in Heart Failure. International Health Economics Association Meeting 2003 

Morrow D, Weiner M, Deer M, Young J, Dunn S, McGuire P, Murray MD. Design and Distribution of 

Patient-Centered Medication. Gerontechnology 2002; 2(1). 

Hope C, Seger A, Teal E, Murray M. Computerized identification of adverse drug events by non-medical 

personnel. J Am Pharm Assoc 2002 

Murray M, Brewer N, Caffrey H, Seshadri R, Marrero D, Lykens M, Tierney W, Weinberger M. 

Pharmaceutical care of airways disease: Results of a prospective, randomized trial. J Am Pharm Assoc 

2002 

Murray MD, Seger A, Hope CJ, Teal E, Mills V, Gandhi T, Overhage JM, Bates DW. Distributions of 

signals suggesting the presence of adverse drug events in outpatients. Clin Pharmacol Ther 2002; 

71:P59. 

Kalinowski A, Murray MD, Seger A, Teal E, Gandhi T, Overhage JM, Bates DW. Positive predictive value 

of signals suggesting the presence of drug allergy in outpatients. Clin Pharmacol Ther 2002; 71:P60. 

Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Wolinsky FD. 

Computer-based outpatient care suggestions for reactive airways disease. J Gen Intern Med. 2002; xx:xx. 

Murray MD, Overhage M, Tierney WM. Computerized guidelines for the management of heart disease in 

primary care: Effects on patient care and outcomes. J Cardiac Failure 2001; 7(Suppl 2):92. 


function with vascular protective medications: A longitudinal analysis of a community-based sample of 

African-Americans. Pharmacoepidemiology and Drug Safety 2001; 10(Suppl 1):S64. 

Weinberger M, Murray MD, Marrero DG, N Brewer, M Lykens, LE Harris, R Seshadri, H Caffrey, JJ 

Newell, J Collins, CJ McDonald, Tierney WM. A randomized trial of pharmaceutical care. J Gen Intern 

Med 2001; 16(Suppl 1):181. 

Murray MD, Lane KA, Gao S, Hall K, Hendrie HC. Medications and cognitive impairment in older African- 

Americans. Clin Pharmacol Ther 2001; 69:83. 

Williams CD, Murray MD, Johnson C. Effectiveness of HMG-Co-A reductase inhibitors in modifying lipid 

profiles in patients with established coronary artery disease. Pharmacotherapy 2000; 20:1233. 

Williams CD, Murray MD, Johnson C. Effectiveness of HMG-Co-A reductase inhibitors in a county 

hospital population. Pharmacotherapy 2000; 20:1233-34. 

Murray MD, Aguirre B, McDonald CJ. Inhaled corticosteroids and adverse gastrointestinal effects. 

Pharmacoepi Drug Safety 2000; 9(Suppl 1):S70. 

Tierney WM, Mamlin LA, Seshadri R, Murray MD, Weinberger M. The ability of peak flow and quality of 

life measurements to predict exacerbations of asthma. J Gen Intern Med 2000; 15:149. 

Murray MD, Aguirre B. Gastrointestinal effects of inhaled corticosteroids. Clin Pharmacol Ther 2000; 

67:103. 



Brater DC, Forthofer MM, Murray MD. Torsemide vs. furosemide in the treatment of heart failure. Clin 

Pharmacol Ther 2000; 67:94. 

Murray MD, Forthofer MM, Bennett SJ, Perkins SM, Stroupe KT, Tierney WM, Brater DC. Effectiveness 

of torsemide and furosemide in the treatment of CHF: results of a prospective, randomized trial. 

Circulation 1999; 100:[Abstract 1568] I-300. 

Bennett SJ, Perkins SM, Bergan KA, Forthofer MM, Murray MD, Brater DC. Beliefs about medication and 

dietary compliance in patients with heart failure. Circulation 1999; 100:[Abstract 1693] I-323. 

Murray M, Stroupe K, Callahan C. Drug supplies and costs for older adults. Clin Pharmacol Ther 1999; 

65:191. 

Murray MD, Underhill MG, Minick SM, Tu W, Zhou X-H. Propensity score, model-based methods, and 

matching to balance treatment groups on important background characteristics. Pharmacoepidemiology 

and Drug Safety 1998; 7(Suppl 2):S125. 

Murray MD, Underhill MG, Minick SM, Tu W, Zhou X-H. Changes in renal function in patients prescribed 

NSAIDs: A profile of six commonly used drugs. Pharmacoepidemiology and Drug Safety 1998; 7(Suppl 

2):S125. 

Bennett SJ, Huster GA, Murray MD, Adams LD, Forthofer MM, Ferguson JA, Tierney WM, Brater DC. 

Social support in inner-city heart failure patients. Circulation 1998; 98(Suppl I):I-64. 

Murray MD, Ferguson JA, Bennett SJ, Adams LS, Forthofer MM, Minick SM, Tierney WM, Brater DC. 

Fewer hospitalizations for heart failure by using a completely and predictably absorbed loop diuretic. J 

Gen Intern Med 1998; 13:18. 

Murray MD, Bennett SJ, Ferguson JA, Adams LS, Forthofer MM, Minick SM, Brater DC, Tierney WM. 

Improved health-related quality of life for heart failure by using a completely and predictably absorbed 

loop diuretic. J Gen Intern Med 1998; 13:19. 

Murray MD, Adams LS, Forthofer MM, Tierney WM, Ferguson JA, Bennett SJ, Brater DC. Decreased 

hospitalizations for CHF by using a completely and predictably absorbed loop diuretic. Proceedings of the 

XIII World Congress of Cardiology 1998. 

Murray MD, Stroupe K, Pierson W, Heyman E, Minick SM, Tierney WM, Brater DC. Torsemide and 

furosemide in the treatment of the edema of heart failure: Interim results of a randomized effectiveness 

trial. Proceedings of the 3 rd Annual Meeting of the International Society for Pharmacoeconomics and 

Outcomes Research. Value in Health 1998; 1:34. 

Barner J, Mason H, Murray M. Willingness to pay for and give time to an asthma management program. 

Am. Pharm. 1998; 38:261. 

Murray MD, Harris LE, Overhage JM, Zhou XH, Smith F, Tierney WM,. Association between medication 

possession ratio and reported compliance. J Gen Intern Med 1997; 12:77. 

Murray MD, Lazaridis E, Kotsanos JG, Tierney WM. Determinants of renal insufficiency in patients with 

non-insulin dependent diabetes mellitus. Pharmacoepidemiol and Drug Safety 1996; 5:S113. 

Murray MD, Stang PE, Tierney WM, Health care utilization by inner-city patients with asthma J Gen 

Intern Med. 1996; 11:52. 



Murray MD, Tierney WM. Predicting exacerbations of reactive airways disease using electronic medical 

records. J Gen Intern Med 1996; 11:52. 

Murray MD, Tierney WM, Using computer-based records to predict mortality risk for inner-city patients 

with reactive airways disease J Gen Intern Med 1996; 11:53. 

Smith DM, Cox MR, Brizendine EJ, Hui SL, Freedman JA, Martin DK, Murray MD. Reducing discharge 

polypharmacy: Making prescriptions easier to cancel did not work. HSR&D Service 13th Annual Meeting, 

Washington, DC. 

Murray M, Brizendine E, Haag K, Sridhara R, Brater C. Effects of electrolyte homeostasis in elderly and 

young persons. Clin Pharmacol Ther. 1995. (Note: Judged one of best submitted.) 

Murray MD, Hall SD, Brater DC. Correlation between NSAID accumulation and creatinine clearance in 

elderly patients without and with renal insufficiency. Clin Pharmacol Ther. 1994; 55:207. 

Gatti G, Brater C, Murray M. Bioequivalence analysis of three generic furosemide products to brand 

name furosemide using a population approach. Clin Pharmacol Ther. 1994;5 5195. 

Hamman MA, Hall SD, Murray MD, Brater DC. Effects of age and renal function on sulindac disposition in 

humans. FASEB Journal 1993; 7:A482 (Abstract 2795). 

Murray MD, Brater DC, Greene PK, Haag KM, Kuzmik KK, Manatunga AK, Mullin MA. Renal effects of 

NSAIDs in healthy persons. Clin Pharmacol Ther. 1992; 53:206. (Note: Judged one of best submitted.) 

Murray MD, Brater DC, Greene PK, Kuzmik DD, Haag KM. Effect of NSAIDs on inulin clearance in 

healthy elderly persons. Clin Pharmacol Ther. 1991; 49:166. 

Brater DC, Greene PK, Murray MD. Renal effects of flurbiprofen in patients with chronic renal 

insufficiency. Clin Pharmacol Ther. 1991; 49:194. 

Murray MD, Brater DC, Tierney WM. Risk of ibuprofen-associate blood pressure increase. Clin 

Pharmacol Ther. 1990; 47:126. 

Murray MD, Brater DC, Tierney WM. Risk of ibuprofen-associated hyperkalemia. J Clin Res Drug Dev. 

1989. 

Murray MD, Brater DC, Tierney WM. Risk factors for ibuprofen-associated renal impairment: Aging and 

coronary artery disease. European J Clin Pharmacol 1989; 36 (Suppl):A253. 

Sambol NC, Dettlebach HR, Cerda JJ, Stewart RB, Brater DC, Murray MD, Sheiner LB. Estimating the 

bioequivalence of furosemide products using a population approach. European J Clin Pharmacol. 1989; 

36 (Suppl):A231. 

Murray MD, Brater DC, Tierney WM. Risk of ibuprofen-associated renal impairment. Clin Pharmacol 

Ther. 1989; 45:158. 

PRESENTATIONS 

Platform, Poster, & Workshops 



Murray MD. The Effects of Domain Genera and Health Knowledge in Processing General and Health 

Texts among Older Adults with Hypertension. Human Factors and Ergonomics Society’s 55 th Annual 

Meeting. Las Vegas, NV, September 19-23, 2011. 

Neyarapally GA, Hammad TA, Pinheiro SP, Iyasu S, Murray MD, Stang P. Application of Quality of 

Evidence Assessment Tools to the Valuation of Pharmacoepidemiologic Safety Studies. ICPE 2011, 

Chicago, IL, August 14-17, 2011. 

Murray MD. Overview of comparative effectiveness research and policy. Keynote presentation. 

Comparative Effectiveness Research: Methodology, Translation, and Policy. The Ohio State University, 

Center for Clinical & Translational Science, Columbus, May 17, 2011. 

Murray MD. The Future of Medication Safety Research (Keynote Speaker), Medication Safety in Saudi 

Arabia: Opportunities and Challenges. Riyadh, Saudi Arabia, March 7, 2011. 

Murray MD. Expert Panel: Designing Pilot Programs to Distribute Patient Medication Information. 

Engelberg Center for Health Care Reform at Brookings Institution. February 23, 2011. 

Murray MD. Adherence to pharmacologic therapy in older adults. Colloquium for the Center on Aging and 

the Life Course. Purdue University, January 14, 2011. 

Murray MD. Adherence to pharmacologic therapy. American Heart Association Annual Meeting. 

Cardiovascular Seminar. Improving Cardiovascular Health Through Adherence: Simple Steps in the Right 

Direction. Chicago, November 14, 2010. 

Murray MD. Implementing research in clinical pharmacy practice in the management of heart failure. 

Plenary presentation. Joint program of the European Society of Clinical Pharmacy and the French Society 

of Clinical Pharmacy, Lyon, France, October 23, 2010. 

Dawson S, Heidrick J, Katz A, Murray M, Ferreri S, Marciniak M. Evaluating the impact of community 

pharmacist–provided education on A1C levels. Poster presentation at the American Pharmacists 

Association Annual Meeting, Washington DC, March 12-15, 2010. 

Murray MD. Improving medication use for low-income heart failure patients. Research Training Grant in 

Health Care Quality and Patient Outcomes. School of Nursing, UNC, November 17, 2009 

Chin J, D’Andrea LD, Morrow D, Stine-Morrow E, Conner-Garcia T, Graumlich J, Murray M. Cognition 

and Illness Experience are Associated with Illness Knowledge Among Older Adults with Hypertension. 

Human Factors and Ergonomics Society 53 rd Annual Meeting (Conference Proceedings). San Antonio, 

TX. October 22, 2009. 

Morrow D, Chin J, Stine-Morrow E, Graumlich JF, Conner-Garcia T, Murray MD. Patient Knowledge and 

Cognition Interact to Influence Health Literacy. First Health Literacy Annual Research Conference, 

National Academy of Sciences, Washington, DC, October 19, 2009. (Poster) 

Murray MD, Sturmer T. Study Design in Comparative Effectiveness Research. AHRQ Annual Meeting. 

Rockville, MD, September 15, 2009. 

Katz AJ, Morrow D, Wu J, Tu W, Murray MD. Impact of Health Literacy on Medication Adherence in 

Older Patients with Chronic Heart Failure. 24 th Anniversary International Conference on 

Pharmacopeidemiology & Therapeutic Risk Management ISPE. Providence, RI, August 15-19, 2009. 

(Poster) 



Morrow D, Chin J, Stine-Morrow E, Graumlich JF, Conner-Garcia T, Murray MD. Health Literacy and 

Self-Care: The Role of Cognition and Knowledge. Symposium Session Title: Predicting Online Search 

Among Elders with Diverse Literacy and Cognitive Abilities; American Psychological Association 117 th 

Annual Convention, Toronto, Canada, August 9, 2009 

Murray MD. The Future of Medication Safety: A Focus on Ambulatory Care. King Saud University. 

Riyadh, Saudi Arabia, April 19, 2009 

Murray MD., et al. Pediatric Medication Safety in the Emergency Setting Meeting: Practical Solutions – A 

Consensus Meeting of National Experts, sponsored by the Health Resources and Services 

Administration, Maternal and Child Health Bureau, EMSC Program, and Children’s National Medical 

Center in partnership with the American Academy of Pediatrics and the Duke University Health System. 

Durham, NC. February 23, 2009 

Murray MD. Tips to Reduce Patient Errors. Wake AHEC. Research Triangle Park, NC, September 11, 

2008 

Wu J, Murray MD, Tu W. Validation of a PK-based Medication Adherence Measure. The First 

International Symposium on Biopharmaceutical Statistics, Society of Biopharmaceutical Statistics. 

Shanghai, China. July 1, 2008 

Murray MD. Measured vs. Assumed Drug Dosing Histories in the Polypharmaceutical Management of 

Congestive Heart Failure: Which Drugs Are Most Important? How Strongly Correlated Are Dosing 

Histories of Multiple Medications? Drug Information Association, Improving Drug Development Using 

Patient Adherence Data in Clinical Trials. Washington, DC. May 6, 2008 

Trontell A, Neyarapally G, Murray MD. Research Collaborations and Multi-Center Studies for Addressing 

Comparative Effectiveness Questions, AHRQ Effective Healthcare Methods Meeting. Rockville, MD. April 

30, 2008 

Murray MD. Non-adherence Increases Hospitalizations and Emergency-Room Visits. Drug Information 

Association, Improving Drug Development Using Patient Adherence Data in Clinical Trials. Washington, 

DC. May 6, 2008 

Murray MD. Approaches to Enhance Drug Safety in the Outpatient Setting. American Society for 

Pharmacology and Experimental Therapeutics. San Diego, CA, April 7, 2008 

Murray MD. Effect of a Pharmacist Intervention on Adherence in Patients with Hypertension. National 

Institutes of Health, Framework for Adherence Research and Translation: A blueprint for the next ten 

years. Jersey City, NJ. March 19, 2008 

Murray MD. Medication instruction by pharmacists. Pharmacy Leader’s Forum, Greensboro, NC, 

February 8, 2008 

Murray MD. 1) Treatment adherence agreement among concurrently administered medications, and 

2) Pharmacist intervention to improve adherence in cardiovascular diseases. European Symposium on 

Patient Compliance and Persistence, Faculté de Médecine Lyon Sud, Lyon, France, November 16, 2007 

Burton M, Overhage J, Hope C, Murray M, Hui S. The Cost of Adverse Drug Events in Ambulatory Care. 

AMIA 2007 Annual Symposium: Biomedical and Health Informatics, Scientific Session S30 Paper, 

Chicago, IL, November 12, 2007 



Murray MD. Promoting Medication Adherence in Outpatients with Cardiovascular Diseases: A Patient- 

Centered Approach. Team Meeting of Global Health Economics Division, Amgen, Inc., Thousand Oaks, 

CA, March 23, 2007 

Murray MD. Drug Safety. Clinical Pharmacology Curriculum Review Course, American Society for 

Clinical Pharmacology and Therapeutics 2007 Annual Meeting, Anaheim, CA, March 21, 2007 

Murray MD. Adventures in Determining How Patients Take Their Pills. Meet the Experts Session, 

American Society for Clinical Pharmacology and Therapeutics 2007 Annual Meeting, Anaheim, CA, 

March 24, 2007 

Murray MD. Effects of a Multilevel Pharmacy-based Intervention on Medication Adherence and Health 

Outcomes in Low-income Patients with Heart Failure: Results of a randomized controlled trial, Fifth 

Annual Health Communication Conference, American College of Physicians Foundation and the Institute 

of Medicine, National Academy of Sciences, Washington, DC, November 29, 2006 

Murray MD. Medication Adherence in Patients with Cardiovascular Diseases. Cardiovascular Disease 

Epidemiology Seminar Series. School of Public Health, UNC-CH, Chapel Hill, NC, October 24, 2006. 

Murray MD. Exploring a Strategic Proposal for the Concept of a Compendium of Safe Medication 

Practices. Panel Session One: Best Practices. USP Patient Safety Stakeholder Forum, Bethesda, MD, 

October 11, 2006 

Murray MD. Problems in pharmacotherapeutics and adherence in aging. The Elderly Patient Symposium. 

10 th Annual Scientific Meeting of the Heart Failure Society of America. Seattle, WA, September 13, 2006 

Murray MD. Coaxing an electronic medical record system to detect adverse drug events and errors. The 

Research Training Grant in Healthcare Quality and Patient Outcomes. NINR 5T32NR008856. School of 

Nursing, UNC-CH, Chapel Hill, NC, April 4, 2006 

Murray MD. Improving medication use in patients with hypertension. NIH study section meeting. 

Overcoming barriers to treatment adherence in minorities and persons living in poverty. Bethesda, MD, 


Murray MD. Heart Failure Management: The Pharmacist Role in Disease Management. Post graduate 

Institute for Medicine and Jobson Education, Breakthroughs in Heart Failure Management: focus on the 

Pharmacist Role Symposium, Las Vegas NV, December 6, 2005 

Murray MD, Young JM, Hoke S, Wanzhu T, Smith, Faye A Weiner, M, Wu J, Morrow DG, Ding Y, 

Stroupe KT, Clark DO, Morris A, Brater DC, Weinberger M. Improving Drug Use in Older Adults with 

Chronic Heart Failure: Results of a Randomized, Controlled Trial. . 21 st International Conference on 

Pharmacoepidemiology and Therapeutic Risk Management, ISPE and Vanderbilt University Medical 

Center. Nashville, TN, August 21-24, 2005 

Aljadhey HS, Murray MD. Cognitive Impairment Associated with H2 Receptor Antagonists in a 

Community-Based Sample of Elderly African Americans. 21 st International Conference on 

Pharmacoepidemiology and Therapeutic Risk Management, ISPE and Vanderbilt University Medical 

Center. Nashville, TN, August 21-24, 2005 (Poster) 

Murray MD. Improving Drug Use for Elderly Heart Failure Patients: Final Report, Second RFA Meeting, 

Testing Interventions to Improve Adherence to Pharmacological Treatment Regimens, May 9 – 10, 2005, 

National Institutes of Health, Bethesda, MD. 



Weiner M, Tu W, Murray MD. Failure to intensify antihypertensive therapy. SGIM 28 th Annual Meeting, 

New Orleans, LA, May 12, 2005. (Poster) 

Tu W, Weiner M, Murray MD. A pharmacy-based intervention reduces emergency-department visits in 

patients with hypertension. SGIM 28th Annual Meeting, New Orleans, LA, May 14, 2005. (Poster) 

Murray MD. Discussant. Pharmacoepidemiology and Modeling. American Society for Clinical 

Pharmacology & Therapeutics Annual Meeting, Orlando, March 3, 2005 

Murray MD. Improving Drug Use in Elderly Heart Failure Patients: Results of a Randomized, Controlled 

Trial. Regenstrief Institute, Indianapolis, November 24,2004. (Podium) 

Murray MD. Inclusion of special populations in clinical trials. Challenges in clinical trial design. American 

College of Clinical Pharmacy Annual Meeting, Dallas, November 2004. (Podium) 

Murray MD. “Use of prescription records to assess adherence”. 2 nd Scientific Conference on Compliance 

in Healthcare Research. Sponsored by the American Heart Association. Washington D.C., May 18, 2004 

(Podium) 

Murray MD. “Effects of Computerized Treatment Guidelines for Outpatient Management of Chronic 

Disease” at Innovations from the field: Implementing Quality Improvement under the New Medicare 

Prescription Drug Benefit”. Sponsored by the American Health Quality Foundation. Washington D.C., May 

11, 2004 (Podium) 

Murray, MD “Improving Drug Use in Chronic Cardiovascular Diseases”. The Ohio State University, 

School of Pharmacy, Columbus, OH. April 19-20, 2004 (Podium) 

Murray MD. Albert Ebert Memorial Annual Lecture, Pharmacoepidemiology: A science shaping practice, 

policy, and public health” Rho Chi Phi Chapter, University of Illinois at Chicago, School of Pharmacy. 

April 14, 2004. (Podium) 

Ahmad, SR, Uhl K, Murray MD (Co-chairs) “Hormone Replacement Therapy: Cardioprotective or a 

Disaster” Annual Meeting American Society of Clinical Pharmacology and Therapeutics, Miami Beach, 

FL. March 24-27, 2004 (Symposium) 

Murray, MD “Health Literacy Predicts Medication Adherence” Annual Meeting American Society of 

Clinical Pharmacology and Therapeutics, Miami Beach, FL. March 24-27, 2004. (Podium) 

Murray, MD “Verbal Comprehension Skills Predict Cardiovascular Medication Adherence” and Chair 

“Improving Asthma Therapy”. DIA 5 th Annual Workshop on Pharmaceutical Outcomes Research. 

Tucson, AZ. January 21-23, 2004. (Podium) 

Murray, MD “Using Electronic Medical Records to Identify Adverse Events and Errors in Outpatients”. 

College of Pharmacy and Science at Thomas Jefferson University, Philadelphia, PA. December 9, 2003. 

(Podium) 

Murray, MD Considerations in the analysis of cohort and case-control studies. Annual meeting of the 

American College of Clinical Pharmacy, Atlanta, GA, November 3, 2003. (Podium) 

Murray, MD Vision, reading, and health literacy as predictors of medication adherence. Annual meeting 

of the American College of Clinical Pharmacy, Atlanta, GA, November 4, 2003. (Poster) 



Murray, MD RFA Meeting Testing Interventions to Improve Adherence to Pharmacological Treatment 

Regimens. Oral presentation, Improving Drug Use for Elderly Heart Failure Patients. National Institutes of 

Health, Bethesda, MD, October 9-10, 2003. (Podium) 

Murray, MD for the Workgroup on Medication Errors in Non-institutional Settings. USP Safe Medication 

Use Expert Committee. Rockville, MD, September 30 – October 1, 2003. (Podium) 

Murray, MD Invited Expert - National Health Information Infrastructure 2003 (NHII) The Department of 

Health and Human Services (DHHS) is taking a leadership role to promote public-private collaboration to 

facilitate NHII progress. This conference brought together all the health information technology 

stakeholders to develop a consensus for national action. Topics of discussion: Research & Population 

Health; Homeland Security; Consumer Health; Financial Incentives; Safety & Quality; Standards & 

Vocabulary; Architecture; and Privacy and Confidentiality. Washington, DC June 30 – July 2, 2003. 

Murray, MD Improving Drug Use in Older Adults with Chronic Cardiovascular Disorders. Gerontology 

Program Faculty Associates Luncheon. Purdue University Center on Aging Research, W. Lafayette, IN, 

April 18, 2003. (Podium) 

Murray, MD RFA Meeting on Overcoming Barriers to Treatment Adherence in Minorities and Persons 

Living in Poverty. Improving Medication Use in Patients with Hypertension, National Heart, Lung, and 

Blood Institute, Division of Epidemiology and Clinical Applications, Behavioral Medicine Research Group, 

Bethesda, MD, April 10-11, 2003. (Podium) 

Murray, MD Improving Drug Use in Chronic Cardiovascular Disease. Oral presentation. America Society 

for Clinical Pharmacology and Therapeutics Annual meeting, Washington, DC, April 5, 2003. (Podium) 

Murray, MD NIH Workshop on Cardiovascular Disease in Chronic Kidney Disease. Improving Drug Use 

for Patients with Hypertension. Arlington, Virginia, March 10 & 11, 2003. 

Murray, MD NIH Requirements for Sharing Research Data. Cancer Control Meeting, Mary Margaret 

Walther Program for Cancer Care - Cancer Pavilion Education Center, Indiana University Medical 

Center. January 8, 2003. (Podium) 

Murray, MD Can Drugs That Improve Vascular Risk Factors Prevent Dementia Among Older Minority 

Patients? Oral presentation. Geriatrics Focus Session: Dementia in Older Minority Populations: 

Prevalence, Preventability and Pharmacotherapeutic Considerations. ACCP Annual Meeting 

Albuquerque, NM October 21, 2002. 

Murray MD Improving medication use in older adults. Oral presentation 8 th Biennial Regenstrief 

Conference Turkey Run State Park; entitled “Determinants of Successful Aging: Developing an Integrated 

Research Agenda for the 21st Century September 30, 2002 – October 2, 2002. 

Murray MD Multilevel Pharmacy Interventions to Improve Drug Use in Patients with Chronic 

Cardiovascular Diseases. Oral presentation. International Conference on Pharmacoepidemiology, 

Educational Symposium entitled Drug Related Problems in the Elderly-Epidemiology, Interventions, and 

Biostatistical Considerations, with Joseph T Hanlon, Duncan R Petty, Carl F Pieper. 

Edinburgh, Scotland, UK, August 21, 2002. 

Murray MD [Symposium co-chair] Drug and Herbal Product Use. Oral presentation. American Society 

for Clinical Pharmacology & Therapeutics (ASCPT) Educational Symposium Drug Interactions with Herbal 

Products and Food Bethesda, MD, July 22-23, 2002. 



Kroth P, Murray MD, McDonald CJ. Are vertebral compression fractures being adequately treated in the 

academic primary care clinic? Oral presentation 2002 Midwest Regional SGIM Meeting September 26- 

28, 2002 

Murray MD. Regenstrief Medical Record System. Seminars in Health Informatics. School of Informatics, 

Indiana University Purdue University at Indianapolis. April 18, 2002 

Murray MD. “Multileveled Pharmacy Intervention In Patients With Chronic Cardiovascular Diseases”, 

Innovative Adherence Priorities, NIH Network for Adherence Research, National Institutes of Health, 

Bethesda, MD, April 2, 2002 

Murray MD. Principles of Secondary Data Analysis. Spring Practice and Research Forum, American 

College of Clinical Pharmacy. Savannah, GA, April 8, 2002 

Murray MD. Funding Sources for Secondary Data Analysis. Spring Practice and Research Forum, 

American College of Clinical Pharmacy. Savannah, GA, April 9, 2002 

Murray MD. Use of the Regenstrief Medical Record System for the Detection of Adverse Drug Events in 

Outpatients. Patient Safety: Issues and Solutions Conference, hosted by M-Plan, Indianapolis, March 28, 

2002. 

Murray MD. Medications: Simplifying the regimen and improving adherence. 5 th Scientific Meeting of the 

Heart Failure Society of America. Washington, DC 09/11/01. (Symposium presentation) 


function with vascular protective medications: A longitudinal analysis of a community-based sample of 

African-Americans. 17 th International Conference on Pharmacoepidemiology, Toronto. 08/26/01. 

(Platform) [Voted by peers as one of the top three oral presentation at conference.] 

Murray MD. Promoting safe medication use in ambulatory settings. 13 th National Conference of the 

National Council on Patient Information and Education, 5/16/01, Bethesda, MD. (Platform) 

Huang S-W, Monane M, Murray MD. Drug interactions with herbal products and foods. American 

Society For Clinical Pharmacology & Therapeutics, 2001 Annual Meeting, Orlando, FL. (Workshop) 

Murray MD (Scientific Session Chair). Use of informatics for clinical trials. Converging Information, 

Technology, and Health Care. Annual Conference of the American Medical Informatics Association. Los 

Angeles, CA 11/06/00. 

Murray MD, Aguirre B, McDonald CJ. Inhaled corticosteroids and adverse gastrointestinal effects. 16 th 

International Conference on Pharmacoepidemiology. Barcelona, Spain 8/23/00. (Platform) 

Murray MD, Aguirre B. Gastrointestinal effects of inhaled corticosteroids. 101 st Annual Meeting of the 

American Society for Clinical Pharmacology and Therapeutics. Los Angeles, CA, 3/15/200 to 3/17/00. 

(Poster) 

Brater DC, Forthofer MM, Murray MD. Torsemide vs. furosemide in the treatment of heart failure. 101 st 

Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. Los Angeles, CA, 

3/15/00 to 3/17/00. (Poster) 

Murray MD, Forthofer MM, Bennett SJ, Perkins SM, Stroupe KT, Tierney WM, Brater DC. Effectiveness 

of torsemide and furosemide in the treatment of CHF: results of a prospective, randomized trial. 

American Heart Association 72 nd Scientific Sessions, Atlanta, GA, 11/8/99. (Poster) 



Bennett SJ, Perkins SM, Bergan KA, Forthofer MM, Murray MD, Brater DC. Beliefs about medication 

and dietary compliance in patients with heart failure. American Heart Association 72 nd Scientific 

Sessions, Atlanta, GA, 11/8/99. 

Murray MD. Information Technology: The infrastructure for improvements to the medication use process, 

Re-engineering the medication use system – a national interdisciplinary conference. Sponsored by the 

Joint Commission of Pharmacy Practitioners, Baltimore, MD, 10/1/99. (Plenary Platform Presentation) 

Murray MD, Kesterson J. Data Extraction from the Regenstrief Medical Record System. Indiana 

University Center on Aging Research, Regenstrief Institute, 8/24/99. (Platform) 

Murray MD. Model-based propensity score vs. model-based methods to balance treatment groups on 

important background characteristics. Joint Statistical Meetings, Baltimore, MD, 8/12/99. (Platform) 

Murray MD, Minick SM, Tu W, Underhill MG, Zhou XH. Use of the propensity score to control 

background characteristics in retrospective studies. 35 th Annual Meeting of the Drug Information 

Association, Baltimore, MD, 6/27/99 – 7/1/99. (Symposium) 

Murray MD, Weinberger M, Tierney WM, Brewer N, Weisburd M, Smith F. Community-based 

pharmaceutical care of patients with reactive airways disease. Pharmaceutical Outcomes Research: 

Past, Present, and Future. Drug Information Association, Seattle, WA, 4/26/99 - 4/27/99. (Workshop) 

Murray MD, Bates DW, Gurwitz JH, Evans S. Strategies to detect and reduce adverse drug events. 100 th 

Annual Meeting of the American Society of Clinical Pharmacology and Therapeutics, San Antonio, TX, 

3/18/99. (Symposium) 

Murray MD, Amery WK, Jones J, Strom B. The dilemma wrapped in a riddle: Protecting patients from 

rare adverse drug events. 100 th Annual Meeting of the American Society of Clinical Pharmacology and 

Therapeutics, San Antonio, TX, 3/19/99. (Workshop) 

Murray MD, Underhill MG, Minick SM, Tu W, Zhou X-H. Propensity score, model-based methods, and 

matching to balance treatment groups on important background characteristics, 14 th International 

Conference on Pharmacoepidemiology, Berlin 8/18/98. (Poster) 

Murray MD, Underhill MG, Minick SM, Tu W, Zhou X-H. Changes in renal function in patients prescribed 

NSAIDs: A profile of six commonly used drugs. 14 th International Conference on Pharmacoepidemiology, 

Berlin 8/19/98. (Poster) 

Murray MD. Pharmacoeconomics and outcomes research: Practical perspectives. Dean’s Industrial 

Council Meeting, Indianapolis, IN, 6/12/98. (Platform) 

Murray MD, Adams LS, Forthofer MM, Tierney WM, Ferguson JA, Bennett SJ, Brater DC. Fewer 

hospitalizations for heart failure by using a completely and predictably absorbed loop diuretic. 

Proceedings of the XIII World Congress of Cardiology 1998, Rio de Janeiro. (Poster) 

Murray MD. Compliance packaging and elderly populations. 6 th Annual National Symposium on Patient 

Compliance: Compliance Packaging – Issues & Answers, The Healthcare Compliance Packaging 

Council, Philadelphia, PA, 4/28/98. 

Murray M. A health information system to improve pharmaceutical care. National Congress on 

Improving Prescribing Practices, Institute for Healthcare Improvement, Minneapolis, MN, 4/8/98. 

Michael D. Murray, PharmD, MPH 25 


Murray M. Moderator, Generic drugs and automatic substitution programs. National Congress on 

Improving Prescribing Practices, Institute for Healthcare Improvement, Minneapolis, MN, 4/9/98. 

Tierney WM, Weinberger M, Murray MD, Lykens M. Community-based pharmaceutical care of reactive 

airways disease training program for CVS pharmacists. Regenstrief Institute, 1/7/98 – 1/9/98. 

Murray MD, Tierney WM. Use of clinical databases in research I. Identification of potential research 

subjects. Regenstrief Institute Fellowship Training Program, Indianapolis, IN, 11/20/97. 

Murray MD. Retrospective cohort studies. Regenstrief Institute Fellowship Training Program, 

Indianapolis, IN, 11/18/97. 

Murray MD, Harris L. Medication Compliance. Regenstrief Institute Fellowship Training Program, 


Murray MD. Interim analysis of hospitalization data: Prospective, randomized trial of torsemide and 

furosemide in the treatment of the edema of heart failure. Torsemide Study Investigator’s Meeting, 

9/17/97. 

Avorn J, Kilo C, Lipton H, Murray M, Schneider P, Solomon D. Collaborative on improving prescribing 

practices, Learning Session 1. Institute for Healthcare Improvement, Landsdowne, VA, 7/27/97 – 

7/29/97. 

Solomon D, Murray MD. Optimal applications for computerized records. Collaborative on improving 

prescribing practices, Learning Session 1. Institute for Healthcare Improvement, Landsdowne, VA, 

7/28/97. (Breakout Session) 

Carlstedt BC, Murray MD. Doctor of Pharmacy clerkship student interaction with a physician order-entry 

system. Annual Meeting of the American Association of Colleges of Pharmacy, Indianapolis, IN, 7/15/97. 

(Poster) 

Murray MD. Pharmacokinetics/dynamics of torsemide in patients with heart failure. International 

Conference on Unat (torsemide), International Press Workshop on Torsemide, Palma de Mallorca, Spain, 

5/6/97. (Platform) 

Murray MD, Harris LE, Overhage JM, Zhou XH, Smith F, Tierney WM,. Association between medication 

possession ratio and reported compliance. 20th Annual Meeting of the Society for General Internal 

Medicine, 5/2/97. (Poster) 

Weinberger M, Tierney WM, Murray MD, Lykens M. Community-based pharmaceutical care of reactive 

airways disease. Training program for Revco pharmacists. Regenstrief Institute 4/8/97 – 4/9/97. 

Murray MD. Information systems and quality assurance: Practice vs. claims data. National Association 

of Boards of Pharmacy/American Association of Colleges of Pharmacy District IV Meeting, Chicago, IL, 

11/9/96. (Platform) 

Murray MD, Lazaridis E, Kotsanos JG, Tierney WM. Determinants of renal insufficiency in patients with 

non-insulin dependent diabetes mellitus. Presented at the 12th International Conference on 

Pharmacoepidemiology, Amsterdam, The Netherlands, 8/26/96. (Poster) 

Murray MD. Chair, Session on NSAIDs. 12th International Conference on Pharmacoepidemiology, 

Amsterdam, The Netherlands, 8/26/96. 



Murray MD, Stang PE, Tierney WM. Health care utilization by inner-city patients with asthma. 19th 

Annual Meeting of the Society for General Internal Medicine, 5/4/96. (Poster) 

Murray MD, Tierney WM. Predicting exacerbations of reactive airways disease using electronic medical 

records. 19th Annual Meeting of the Society for General Internal Medicine, 5/4/96. (Platform) 

Murray MD, Tierney WM. Using computer-based records to predict mortality risk for inner-city patients 

with reactive airways disease. 19th Annual Meeting of the Society for General Internal Medicine, 5/4/96. 

(Poster) 

Murray MD. Variability of furosemide absorption in elderly patients. Health Services Research and 

Development Section at the VA in Indianapolis, IN, 9/95. (Platform) 

Murray MD. Prospective, randomized trial of torsemide and furosemide in the treatment of the edema of 

heart failure. Health Services Research and Development Section at the VA in Indianapolis, IN, 3/96. 

(Platform) 

Coordinator, Pharmacoepidemiology training program for six pharmacists from Thailand (Pharmacy 

Faculty (n=3), Thai FDA (n=2), Ministry of Health (n=1). Indianapolis and West Lafayette, IN, 8/7/95 – 

9/12/95. 

Faculty, International Workshop on Pharmacoepidemiology and Pharmacoeconomics for the 

Implementation of National Drug Policy, Chiangmai, Thailand, 4/17/95 – 4/21/95. (Workshop) 

Murray MD. An overview on pharmacoepidemiology observations in institutional settings. International 

Workshop on Pharmacoepidemiology and Pharmacoeconomics for the Implementation of National Drug 

Policy, Chiangmai, Thailand, 4/17/95. (Platform) 

Hartzema AG, Murray MD. Current issues in pharmacoepidemiology studies. International Workshop on 

Pharmacoepidemiology and Pharmacoeconomics for the Implementation of National Drug Policy, 

Chiangmai, Thailand, 4/18/95. (Platform) 

Schondelmeyer SW, Hadsall RS, Hartzema AG, Murray MD. Information systems for 

pharmacoepidemiologic and pharmacoeconomic studies. International Workshop on 

Pharmacoepidemiology and Pharmacoeconomics for the Implementation of National Drug Policy, 

Chiangmai, Thailand, 4/21/95. (Platform) 

Murray M, Brizendine E, Haag K, Sridhara R, Brater C. Effects of electrolyte homeostasis in elderly and 

young persons. American Society of Clinical Pharmacology and Therapeutics 96th Annual Meeting, 

3/17/95 in San Diego, CA. (Platform) 

Murray MD. Drug compliance and misuse. Geriatrics Noon Conference. VA Medical Center, 

Indianapolis, IN, 10/4/94. (Platform) 

Smith DM, Cox MR, Brizendine EJ, Hui SL, Freedman JA, Martin DK, Murray MD. Reducing discharge 

polypharmacy: Making prescriptions easier to cancel did not work. HSR&D Service 13th Annual Meeting, 

Washington, DC, 3/2/95. 

Murray MD. Drug compliance and misuse. Geriatrics Noon Conference. VA Medical Center, 




Feinberg JL, Perfetto E, Murray MD, Stek M. Research planning and proposal writing: An interactive 

seminar for consultant pharmacists. Two two-day seminars for consultant pharmacists sponsored by the 

American Society of Consultant Pharmacists and Merck & Co. 6/25-26/94 in Chicago, IL and 10/1-2/94 in 

Baltimore, MD. (Workshops) 

Murray MD. Health services utilization among inner-city patients with asthma. Glaxo Research Institute, 

Pharmacoeconomics Research, Research Triangle Park, NC, 5/5/94. (Platform) 

Murray MD. Drug epidemiology. Multidisciplinary perspectives on aging, CDFS 565. Purdue University, 

Karen Altergott, Ph.D. (Coordinator) (Biannual lecture) 

Murray MD, Hall SD, Brater DC. Correlation between NSAID accumulation and creatinine clearance in 

elderly patients without and with renal insufficiency. 95th Annual Meeting of the American Society for 

Clinical Pharmacology and Therapeutics. New Orleans, LA, 4/1/94. (Poster) 

Murray MD. Correlation between NSAID accumulation and creatinine clearance in elderly patients 

without and with renal insufficiency. Indiana University School of Medicine, Clinical Pharmacology 

Division, Indianapolis, IN, 3/22/94. (Poster) 

Murray MD. Morbidity, mortality, and use of health care services in patients with chronic respiratory 

disease. Caremark Prescriptions Services, Chicago, IL, 3/11/94. (Platform) 

Grantsmanship: Research planning and proposal writing. [Workshop co-sponsored by the Agency for 

Health Care Policy Research and American Society of Hospital Pharmacists (ASHP)]. With Feinberg J, 

Hanlon J, and Perfetto E (coordinator), ASHP Midyear Meeting, Atlanta, GA, 12/4/93. (Workshop) 

Murray MD. Blood pressure medications. Indianapolis Senior Citizens Center. (with Duncan K, Kuehl S, 

Stotelmeyer C, Wall D) 11/16/93. 

Murray MD. Acute and chronic renal effects of NSAIDs in elderly patients without and with renal 

insufficiency. Clinical Pharmacology Noon Meeting. Indiana University School of Medicine, 10/26/93. 

Murray MD, Mead J, Kania D, Whaley T, Bickert B. Indianapolis Senior Citizens Center Health Fair, 

10/18/93. 

Pharmacoepidemiology at the Indiana University Medical Center, Department of Pharmacy Practice 

Seminar, Purdue University, 9/3/93. 

Murray MD. Report of the Membership & Public Relations Committee, 9th International Conference on 

Pharmacoepidemiology, Washington, DC, 8/31/93. 

Murray MD. Pharmacokinetics of the NSAIDs. National Consensus Council on OTC Analgesics, Fort 

Lauderdale, FL, 4/16/93. (Platform) 

Murray MD, Brater DC, Greene PK, Haag KM, Kuzmik DD, Manatunga AK, Mullin MA. The effects of 

NSAIDs on renal function in healthy elderly persons. 94th Annual Meeting, American Society of Clinical 

Pharmacology & Therapeutics, Plenary Platform Presentation, Honolulu, HW, 3/25/93. 

Murray MD. The effects of NSAIDs on renal function in elderly persons with and without renal 

insufficiency. Clinical Pharmacology Seminar, Indiana University School of Medicine, 11/10/92. 

Murray MD. International Society for Pharmacoepidemiology, Membership Services Committee Report, 

Minneapolis, MN 9/1/92. 



Murray MD. Regenstrief Medical Records System. Harvard University Program for the Analysis of 

Clinical Strategies. 7/23/92. (Platform) 

Murray MD. Drug interactions. Mary Riggs Senior Citizens Center, 5/19/92. 

Murray MD. The more you know (about your medications) the better you'll feel. Indianapolis Senior 

Citizens Center Open House, 4/21/92. 

Brater DC, Murray MD, Haag K. Medications: Be an informed consumer. 1991 Indiana Governor's 

Conference on Aging, 11/19/91. 

Murray MD, Haag K. Communication with your doctor and pharmacist about your medications. 

Indianapolis Senior Citizens Center, 10/15/91. 

Edlavitch SA, Murray MD. International Society for Pharmacoepidemiology, Membership Services 

Committee Report, Basel, Switzerland 8/26/91. (Platform) 

Murray MD. Medication compliance in elderly patients. Clinical Pharmacology Division, Indiana 

University School of Medicine, 6/4/91. (Platform) 

Murray MD. Drugs and the elderly. Housestaff Pharmacology Conference, University Hospital, Indiana 


Murray MD. The effects of NSAIDs on renal function of healthy elderly persons. Clinical Pharmacology 

Seminar, Indiana University School of Medicine, 1/25/91. (Platform) 

Murray MD. Manipulation of large data sets: Pharmacoepidemiology. 25th Midyear Clinical Meeting of 

the American Society of Hospital Pharmacists, SPG on Geriatrics, Las Vegas, NV, 12/5/90. (Platform) 

Drug Utilization Review Workshops. Criteria Panel Member, Sponsored by the American Society for 

Clinical Pharmacology & Therapeutics, Geriatric Pharmacy Institute of the Philadelphia College of 

Pharmacy & Science, and the Center on Drugs & Public Policy of the University of Maryland, Rockville, 

MD, 11/26-27/90. 

Murray MD. Statistical approaches to repeated measures data. Clinical Pharmacology Division, Indiana 


Murray MD. International Society for Pharmacoepidemiology, Membership Services Committee Report, 

Anaheim, CA, 8/11/90. 

Murray MD, Brater DC, Tierney WM. Risk of ibuprofen-associated blood pressure increase. 90th Annual 

Meeting of the American Society for Clinical Pharmacology and Therapeutics. San Francisco, CA, 3/90. 

(Poster) 

Murray MD, Brater DC. Determinants of ibuprofen-associated renal impairment. Food and Drug 

Administration Arthritis Advisory Committee, Washington, DC. 2/23/90. (Platform) 

Murray MD, Brater DC, Tierney WM. Risk of ibuprofen-associated hyperkalemia. Fourth International 

Conference on Pharmacoepidemiology. Minneapolis, MN, 9/89. (Poster) 



Murray MD, Brater DC, Tierney WM. Risk factors for ibuprofen-associated renal impairment: Aging and 

coronary artery disease. IV World Conference on Clinical Pharmacology and Therapeutics, Mannheim- 

Heidelberg, 7/26/89. (Poster) 

Murray MD, Brater DC, Tierney WM. Determinants of ibuprofen-associated renal impairment in patients 

from a large general internal medicine practice. 90th Annual Meeting of the American Society of Clinical 

Pharmacology & Therapeutics, Nashville, TN, 3/89. (Platform) 

Murray MD. NSAIDs and peptic ulceration among the elderly. Seminars in Clinical Pharmacy. Methodist 

Hospital, Indianapolis, IN, 2/89. (Platform) 

Murray MD. Substance abuse by older adults. Indiana University School of Nursing, Physical Aspects of 

Aging Course, 11/88. (Lecture) 

Murray MD, Brater DC. Detecting drug-related problems in the elderly. Indianapolis Senior Companion 

Program, Catholic Center, Indianapolis, IN, 4/88. (Platform) 

Murray MD. Determinants of ibuprofen-associated renal dysfunction in a large general medicine 

practice. Indiana University School of Medicine, Clinical Pharmacology Seminar, 3/88. (Platform) 

Murray MD. Pharmacoepidemiologic approach to assessing the renal effects of NSAIDs. Indiana 

University School of Medicine, Clinical Pharmacology Seminar, 10/87. (Platform) 

Murray MD. Antibiotic therapy in the critically ill patient. Indiana Society of Hospital Pharmacists Fall 

Meeting, 10/87, Fort Wayne, IN. (Platform) 

Murray MD, Tierney WM, Brater DC, Stone MB. Ibuprofen use and renal dysfunction. 3rd International 

Conference on Pharmacoepidemiology, 9/87, Minneapolis, MN. (Poster) 

Murray MD. Antibiotic control programs. Division of Infectious Disease Faculty Meeting, Indiana 

University Medical Center, 4/27/87. (Platform) 

Murray MD, Main JW, Kohler RB. Effect of an antibiotic control program on antibiotic costs in a county 

hospital. 26th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, 9/86, New 

Orleans, LA. (Poster) 

Murray MD. Antibiotic update. Indiana Society of Hospital Pharmacists - Region I, 7/86, Indianapolis, IN. 

(Platform) 

Murray MD, Hancock BG, Main JW. Cost containment through a reserved antibiotic program. Indiana 

Society of Hospital Pharmacists Annual Meeting 1986, Indianapolis, IN. (Platform) 

Hancock BG, Schechter BM, Main JW, Murray MD (Symposium coordinators). Update on ACE inhibitorsfocus 

on enalapril, 1986, Indianapolis, IN. 

Murray MD, Schechter BM. Drug problems in the elderly. Indiana University School of Nursing, 1986 

and 1987, Indianapolis, IN. (Lecture) 

Murray MD, Hancock BG, Lamy Y, Everly M. Maxzide to Dyazide conversion: Role of the pharmacy and 

therapeutics committee. American Society of Hospital Pharmacists Midyear Clinical Meeting 1985, New 

Orleans, LA. (Poster) 



Murray MD. Identifying and managing problems patients have with their medications: Emphasis on the 

Elderly. Pharmacy Alumni Seminar 1985, Purdue University. (Platform) 

Murray MD. Drug therapy in the elderly. Indiana Center on Aging, Indianapolis, IN, 1984. (Platform) 

Murray MD. Geriatric health care services. Fall Pharmacy Practice Conference 1984, Purdue University. 

(Platform) 

Carlstedt BC, Murray MD. Facilitating Doctor of Pharmacy student development through comprehensive 

specification of knowledge and skill expectations. American Association of Colleges of Pharmacy Annual 

Meeting 1984, Baltimore, MD. (Poster) 

Scott SA, Murray MD, Carlstedt BC, Hancock BG. Development of standardized evaluation form for use 

in Doctor of Pharmacy clerkships. American Association of Colleges of Pharmacy Annual Meeting 1983, 

Washington, DC. (Poster) 

Carlstedt BC, Hancock BG, Murray MD, Scott SA. Videotaped case presentations for verbal skill 

development evaluation in Doctor of Pharmacy clerkships. American Association of Colleges of 

Pharmacy Annual Meeting 1984, Washington, DC. (Poster) 

TEACHING ACTIVITIES 

Purdue University 

PHAD 46400: Pharmacy Administration, Management of Pharmacy Practice, Fall 2010/2011. 

Pharmacoepidemiology, pharmacoeconomics, decision analysis. 

Indiana University 

G660: Clinical Research Methods, Fall 2010. Use of clinical databases/EMRs in research. 

Fall 2011. Comparative effectiveness research 

University of North Carolina at Chapel Hill courses taught over past 5 years 

Didactic: Courses coordinated are indicated in bold-face type 

Year Semester Course # Students Lecture Hours 

2008 Fall PHCY 433 145 14 

2008 Fall DPOP 899 10 1 

2008 Fall DPET 833 17 1 

2007 Spring DPOP 899 8 1 

2007 Fall PHCY 433 147 10 

2007 Fall DPET 833 12 1 

2006 Spring 

DPOP 899 

(DPOP361 

PPES 361) 

8 1 



2006 Spring PHTH 81 15 1 

2006 Fall PHCY 433 147 14 

2006 Fall DPET 833 12 1 

2005 Fall 

PHCY 433 

(PHCY 74) 

120 14 

2005 Fall EPID 232 15 1 

2005 Fall 

DPOP804 

PPES 254 

Course abbreviations and descriptions: 

15 10 

PHCY 433 (PHCY 74): Drug Literature Analysis and Interpretation (4 credit hours) 

Module III: Evidence-based Health Care and Critical Appraisal. Students in the second 

professional year learn the tools of evidence-based therapeutics and critical appraisal of the 

literature and their relevance to life-long learning. Topics include causal inference, study design, 

introduction to evidence-based medicine and critical appraisal of conduct of randomized clinical 

trials; cohort, case-control, and cross-sectional studies; bias in clinical research; and pharmacy 

practice research. 

PHTH 81: Pharmacy Practice of Geriatric Patients 

Introduces students to important principles of drug therapy management in the older adult, and 

provides opportunities to apply and practice these principles. 

DPOP 804 (PPES 254): Informatics: Use of Large Health Care Databases (5 credit hours) 

and weekly 3-hour analysis laboratory session. 

This is an interdisciplinary course providing practical training in the analysis of large secondary 

databases containing physician, hospital, and prescription data. Course topics include 

preparation, algorithm development, quality control, and dataset limitations. The course provides 

graduate students and professional students planning a career in health services research and/or 

pharmacoepidemiology an introduction to secondary data analysis. The course explores the 

challenges and opportunities of working with large health datasets, including databases created 

for administrative and clinical purposes. In addition, the course will help prepare students for 

careers in research and program evaluation. 

DPOP 899 (DPOP361 PPES 361): Seminar. Emphasis: Pharmaceutically-Relevant Health 

Policies and Outcomes 

The graduate seminar is intended as an opportunity for graduate students to discuss topical 

issues not otherwise covered in core classes. 

DPET 833: Experimental Design Considerations in Clinical Research. 

Observational (epidemiologic) study designs: Case-control, cross-sectional, cohort studies. 

EPID 232: Applications of Medication Adherence Methods 

Describe ongoing studies to improve medication adherence, types of adherence measured and 

relevant methods, and the results of the interventions. 

Graduate Students Supervised 



PhD, Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy 

Melissa Butler, PharmD, MPH, PhD 

Dissertation Committee Chair 

Dissertation Title: The Role of Patient Activation in Medicare Prescription Drug Coverage 

Information Seeking 

Completed: 05/2010 

Current Position: Research Scientist, Kaiser-Permanente, Atlanta 

Hisham Aljadhey, MS, PharmD, PhD 


Dissertation Title: The Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on Blood 

Pressure in Patients with Hypertension 


Current Position: Vice-Dean and Medication Safety Research Chair, College of Pharmacy, King 

Saud University 

Mark A. Patterson, MS, PhD 


Dissertation Title: Effects of Prescription Copayments on Medication Compliance and 

Hospitalizations in Commercially Insured Patients with Heart Failure 


Current Position: Assistant Professor, DPPA, School of Pharmacy, UMKC 

Current Position: Health Services Research Analyst, Div of Health Services & Social Policy, 

Dept of Health Care Quality & Outcomes, Research Triangle Institute (RTI) 

Aaron Katz 

Student Advisory Committee Chair 

Expected Completion Date: 2012 

PhD, Department of Health Policy and Management, UNC Gillings School of Public Health 

Lynn Redington, MPH, MBA, DrPH 

Dissertation Committee Member 

Dissertation Title: The Orphan Drug Act of 1983: A Case Study of Issue Framing and the 

Failure to Effect Policy Change from 1990-1994 

Completed: March 2009 

PhD, Purdue University 

Todd Roswarski, PhD Psychology 


Dissertation Title: Human decision making in medicine: A survey of professional characteristics 

and practices 

Completed Date: 2001 

Current Position: Assistant Dean, Ivy Tech College - Lafayette) 

Michelle Chui, PhD, Purdue 

Co-major Professor with Holly Mason, Ph.D. 

Dissertation Title: Diuretic compliance, quality of life, and health care utilization in patients with 

heart failure 


Current Position: Associate Professor of Pharmacy, University of Wisconsin – Madison 



Jamie Barner, PhD 

Co-major Professor with Holly Mason, Ph.D. 

Dissertation Title: Assessment of asthma patient’s willingness to pay for and give time to an 

asthma self management program 


Recognition: Jenkins/Knevel Award Winner for Best Research Project, Purdue 

Current Position: Professor of Pharmacy, University of Texas - Austin 

Fellows, Purdue University 

Andrew Morris, PharmD 

Research Project: Improving medication use for patients with hypertension 

Dates: 2003 – 2005 

Current Position: Assistant Professor, Hampton Veterans Administration Medical Center 

Carol Hope, MS, PharmD 

Research Project: Improving drug use for elderly heart failure patients; Improving drug safety 

with computer prescribing. 

Dates: 2001 – 2003 

Current Position: Veterans Administration Salt Lake City Informatics Decision Enhancement 

and Surveillance Center 

Fellows, Indiana University 

Phillip Kroth, MD 

Dates: 2001 – 2003 

Research Project: Vertebral fracture treatment study 

Current Position: Assistant Professor & Assistant Director Health Sciences Informatics 

Program Development, Health Sciences Library and Informatics Center University of New 

Mexico 

Kevin Stroupe, PhD 

Dates: 1998 – 1999 

Current Position: Acting Director, Acting Director VA Information Resource Center (VIReC) 

Midwest Center for Health Services and Policy Research; Cooperative Studies Program 

Coordinating Center, Northwestern University and Hines Veterans Administration 

Margaret Brunt, MD 

Research Project: Prepublication Release of medical research results: An analysis of 

antihypertensive drug prescribing in the aftermath of the calcium channel blocker scare of 

March 1995 

Dates: 1997 – 1999 

Current Position: Assistant Professor of Medicine and Clinical Pharmacology, University of 

Manitoba 

FUNDED GRANTS & CONTRACTS 

(Note that dollar figures in parentheses are amounts of grants and subcontracts paid to Schools). 

Shekhar A, Tierney WM, Hudson B, McGuire P, Rosenman M, Murray MD. NCRR Administrative 

Supplement to Advance Translational (T1 & T2) Research CI Net. ($53,005) 



Murray MD. Regenstrief Center for Healthcare Improvement and Research, 05/2010, ($23,020). 

Maciejewski M (PI), Farley JF, Hansen RA, Murray MD. Medication Dedication Evaluation/Interventions 

Contract (Statement of Work # 1 & 2). Blue Cross Blue Shield of North Carolina (BCBSNC) 10/01/2008- 

03/31/2009 $54,000. 

Morrow DG, Stine-Morrow EAL, Graumlich JF, Murray MD (co-PI). Health literacy and aging: A processknowledge 

approach. National Institute on Aging, (R01 AG031718). 03/01/2008-02/28/2013. $1,687,048 

Murray MD (PI) Sturmer T (co-PI). Developing Evidence to Inform Decisions about Effectiveness: The 

DEcIDE Network, Awarded by AHRQ, 09/16/2005 -02/01/2011. $20,000 (HHSA290-2005-040I) Note: 

Murray replaced West as PI with Sturmer named co-PI on 11/28/2007. 

� Gaynes B (Project Co-PI), Hansen RA (Project Co-PI). Addressing Knowledge Gaps in the 

Treatment of Depression. Task Order No. 2. 07/15/2008-01/15/2011. $359,780. 

� Carpenter W (Project PI), Weiner B, Goldberg R, Carey T, Murray MD. The Cancer Multi-Center 

Research Consortium – Affiliate Center, Task Order No. 4. estimated cost. 09/04/2008- 

09/30/2010, $450,000. 

HHSA290-2005-0040-I-T04-WA1 Health Outcomes of Colorectal Cancer Chemotherapy. 

02/25/2009-09/30/2010, $440,000. 

HHSA290-2005-0040-I-T04-WA2 Analytical Briefs for Supporting Comparative Effectiveness 

Research and Systematic Reviews in Cancer. Phase I – Identifying Options for 

Implementation. 02/16/2009-03/31/2009, $10,000. 

HHSA290-2005-0040-I-T04-WA3 Evaluating Outcomes of PET Scanning Using the National 

Oncologic PET Registry. 03/31/2009-05/31/2009, $33,475. 

HHSA290-2005-0040-I-T04-WA4 Retrospective Evaluation of Outcomes of PET Scanning 

Using the National Oncologic PET Registry. 09/01/2009-09/30/2010, $500,000. 

HHSA290-2005-0040-I-T04-WA5 Data Committee Support for the DEcIDE Cancer 

Consortium. 08/01/2009-09/30/2010, $175,000. 

Murray MD (PI) Clinical Trials Data Analysis, GlaxoSmithKline. 10/01/2006 – 12/31/2007, $54,795. 

Sleath B (PI), Johnson J, Murray M. UNC/GSK Latino Health Partnership, GlaxoSmithKline. 08/01/2006 

– 07/31/2007, $44,672. 

Murray MD. Drug-induced Long QT Interval Feasibility Study, First Genetic Trust, Inc. 01/2004 – 

04/2004, $5000 

Murray MD. Actos – Avandia Heart Failure Feasibility Study, First Genetic Trust, Inc. 01/2004 – 04/2004, 

$5000 

Thomas Inui, MSc, MD, Julie Meek, DNS (co-principal investigators), Marc Rosenman, MD Timothy 

Stump, MSc, Jingjin Li, PhD, Murray MD. Haelan Group - Regenstrief Institute Indiana State 21 st Century 

Application (11/07/2003) 



Thomas Inui, ScM, MD (principal investigator), Steve Downs, MD (Co-principal investigator), Marc 

Rosenman, MD, Ron Ackerman, MD, Murray MD (co-investigator), Barry Katz, PhD, Ann Holmes, PhD. 

Indiana Medicaid Chronic Disease Management Program. Indiana Office of Medicaid Policy & Planning, 

in concert with the Indiana State Department of Health has initiated a program to assist in the 

management of patients with chronic diseases, such as diabetes, congestive heart failure, and pediatric 

asthma. Regenstrief Institute will provide technical support for the program’s design, implementation, 

decision support, personnel training and patient education, and the evaluation of impacts to cost and 

quality. 08/01/03 – 07/31/05 ($500,000 in year one). 

Murray MD. Regenstrief Institute Health Data & Epidemiology Section Core Support. The purpose of 

these funds is to support the activities of data analysts who work for Regenstrief Institute from 7/1/2003 to 

6/30/2004. Regenstrief Foundation. $221,592 ($113,000 direct/$108,592 overhead allocation). ($12,911) 

Murray MD, Inui TS. John M. Eisenberg Memorial Lectureship on Therapeutic Research, funded by the 

Agency of Healthcare Research and Quality (AHRQ)and the Centers for Education & Research on 

Therapeutics [Richard Platt, MD] 4/24/03 – 12/31/03 

Murray MD (principal investigator), Weiner M, Clark DO, Hendrie HC, Kroenke K, Morrow DG, Pratt JH, 

Stroupe KT, Tu W. Improving medication use for patients with hypertension. (R01 HL69399). 

($2,059,637) 09/30/2001 – 08/31/2006. 

Murray MD (principal investigator), Weiner M, Weinberger M, Sowinski K, Morrow D, Stroupe K, Tu W, 

Clark D, Murray L. Improving drug use for elderly heart failure patients. (R01 AG19105) ($1,481,388). 

9/30/2000 – 8/31/2004. 

Chalasani N, Murray MD. (co-investigator). Collaborative Clinical Research on Hepatotoxicity (RFA: DK- 

02-033) 07/01/03 – 06/30/06. $247,104 per year direct cost. ($10,705). 


these funds is to support the activities of seven Masters-level data analysts from 7/1/2002 to 6/30/2003 

who work for Regenstrief Institute. Regenstrief Foundation. $573,515 ($453,862 direct/$119,653 

overhead allocation). ($13,259) 


these funds is to support the activities of seven Masters-level data analysts from 7/1/2001 to 6/30/2002 

who work for Regenstrief Institute. Regenstrief Foundation. $331,903 ($195,458 direct/$136,445 

overhead allocation). ($10,000) 

Murray MD (principal investigator). Hospital admission and post-discharge survival of patients with heart 

failure. Biogen, Inc. $15,000. 

Murray MD. Regenstrief Institute Health Data Core Support. The purpose of these funds is to support the 

activities of seven Masters-level data analysts from 7/1/2000 to 6/30/2001 who work for Regenstrief 

Institute. Regenstrief Foundation. $316,857 ($194,297 direct/$122,560 overhead allocation). ($28,856) 

Bates DW, Gandhi T, Overhage M, Murray MD (co-investigator). Improving safety by computerizing 

outpatient prescribing. 9/16/2000 - 8/31/2003 (U18-HS11046). $856,628 ($112,819) Subcontract from 

Brigham & Women’s Hospital to support 20% effort. 

Brater DC, Gradus-Pizlo I, Murray MD (co-investigator), Gorski JC, Zhou XH. Clinical pharmacology of 

the loop diuretics. 20% effort, R01 AG 07631 (Brater NIH renewal). ($250,000 direct/year) 9/01/2000 - 

8/31/2006. 



Brater DC, Hall SD, Murray MD (co-investigator), Gorski JC, Zhou XH, Jones Dr, McDonald CJ. Clinical 

Pharmacology Training Grant. Food & Drug Administration. 2/15/2000 – 2/14/2003. Direct Cost $469,744 

per year. 

Murray MD. Regenstrief Institute Health Data Core Support. The purpose of these funds is to support the 

activities of seven Masters-level data analysts from 7/1/1999 to 6/30/2000 who work for Regenstrief 

Institute. Regenstrief Foundation. $248,561 ($162,872 direct/$85,689 overhead allocation). ($27,000) 

Breitfeld PP, Murray MD (investigator), Forthofer M, Vik T, Harley J. Comprehensive assessment of 

medication compliance in children with acute lymphoblastic leukemia. Walther Cancer Research. 

($29,981) 

Murray MD (sponsor to Patricia Engle, Pharm.D.) Predictors of anticonvulsant serum concentrations and 

therapeutic outcomes in older adults, Merck/AFAR Scholarships in Geriatric Pharmacology for Medical 

and Pharmacy Students, 1999. ($4,000) 

Murray MD (principal investigator) Intervention on albumin prescribing: A proposal to VHA from Clarian 

Health Partners, Inc., 1999. $255,274 

Murray MD (principal investigator). Clarian Health Pharmacy Decision Support. Proposal to Clarian 

Health to create center. $149,920 over 18 months. (Partial program costs over six months were awarded 

as a contract.) 

Murray MD (principal investigator). Use of the propensity score to control background characteristics in 

retrospective studies. Drug Information Association Research Grant Program, 1998. $23,000 

Menon U, Rawl S, Champion V, Murray MD (co-investigator). Comparison of self-reported utilization of 

colorectal and breast cancer screening tests and medical record data. Donating time to help with patient 

identification and data retrieval, 1998. 

Bennett SJ, Murray MD (co-principal investigator), Oldridge N, Huster G. Comparison of quality of life 

measures in heart failure. Agency for Health Care Policy and Research, 1998. ($49,992) 

Murray MD (principal investigator), Brater DC, Tierney WM. Prospective, randomized trial of torsemide 

and furosemide in the treatment of the edema of heart failure. Boehringer Mannheim Pharmaceuticals, 

Inc. (Year 3 Continuation Grant $147,245 1998) ($63,925) 

Murray MD (principal investigator), Brater DC, Tierney WM. Prospective, randomized trial of torsemide 

and furosemide in the treatment of the edema of heart failure. Boehringer Mannheim Pharmaceuticals, 

Inc. (Year 2 Continuation Grant $45,934 1997) ($61,469) 

Murray MD. Director, Regenstrief Institute Data Core. Purpose of funding: Remuneration for overseeing 

activities of seven data managers at the Regenstrief Institute for Health Care Research, $21,245, 1997- 

1998. ($18,073) 

Tierney WM, Murray MD (co-principal investigator). Pharmacoepidemiologic studies using the 

Regenstrief Medical Record System. Eli Lilly & Company, 1/1/97 through 12/ 31/99. Purpose of funding: 

Educate and oversee a masters-level statistician dedicated to extracting and manipulating data from the 

RMRS, primarily for the conduct of pharmacoepidemiologic research. $189,416 (for statistician's salary 

support), 1996-1998. 

Murray MD, Tierney WM. Effect of ondansetron on cisplatin and cyclophosphamide chemotherapy 

dosing and patient survival. GlaxoWellcome Research and Development. ($14,580) 



Weinberger M, Tierney WM, Murray MD (co-investigator). Community-based pharmaceutical care: A 

controlled trial. Agency for Health Care Policy and Research. RO1 HS09083. $2,093,261, 1996. 

($184,500) 

Brater MD, Tierney WM, Murray MD (co-principal investigator). Drug utilization data collection consortium 

project. Pfizer, Inc., 1996. $80,000 

Murray MD (principal investigator), Brater DC, Tierney WM, Ferguson J. Prospective, randomized trial of 

torsemide and furosemide in the treatment of the edema of heart failure. Boehringer Mannheim 

Pharmaceuticals, Inc. $280,138, 1996. ($33,528) 

Murray MD (principal investigator), Tierney WM. Prevalence of H2 antagonist use in patients prescribed 

NSAIDs. G.D. Searle & Company, 1995. ($10,000) 

Murray MD (co-principal investigator), Tierney WM, McDonald RC, Kotsanos JG. Longitudinal effects of 

blood pressure on renal function in diabetes mellitus. Eli Lilly and Company, 1995. ($28,099) 

Murray MD (principal investigator). Medication compliance in patients with heart failure using Medication 

Event Monitoring Systems (MEMS), 1995. (Approx. $1,000) 

Murray MD (co-principal investigator), Brater DC. Population pharmacokinetics and pharmacodynamics 

of terfenadine and metabolites, Coordinator of this multicenter trial involving Indiana University, Iowa 

University, and University of Texas at San Antonio, Marion Merrell Dow, Inc. $404,431 1993. ($31,1F63) 

Tierney WM, Overhage M, Murray MD (co-investigator), Harris L. Computer-based prospective drug 

utilization review. Agency for Health Care Policy & Research. RO1 HS07763 $1,297,444, 1993. 

($153,687) 

Murray MD (principal investigator), Tierney WM. Asthma in a minority inner-city population, from Glaxo, 

Inc., 1991. ($38,000) 

Murray MD (principal investigator). Hypoglycemic episodes among general medicine clinic patients 

treated with glyburide or glipizide. $1,000 to initiate study from Roerig, Division of Pfizer, 1990. ($1,000) 

Darnell JC, Murray MD (co-principal investigator). Improved drug compliance in elderly living in the 

community by using unit-of-use medication packaging and twice daily dosing, $51,011 proposal to the 

Metropolitan Health Council of Indianapolis, Incorporated 1989. ($50,000) 

Murray MD (principal investigator), Brater DC. Outcome of general medicine clinic patients treated with 

glyburide or glipizide. $6,000, Hoechst Pharmaceuticals, Inc. and the Upjohn Company, 1989. ($6,000) 

Murray MD (principal investigator), Brater DC. Dosage requirements and blood glucose control among 

patients from a general medicine practice treated with glyburide or glipizide. $6,000 Upjohn Company and 

Hoechst Pharmaceuticals, Inc., 1989. ($6,000) 

Brater DC, Murray MD (co-principal investigator), Sambol NC. A population pharmacokinetic/dynamic 

study of generic v. brand name furosemide. $20,000 for MDM component from Hoechst Pharmaceuticals, 

Inc., 1989. ($20,000) 

Murray MD (principal investigator). Third-generation cephalosporin use at a city-county hospital. $1,300 

from Hoechst Pharmaceuticals, Inc., 1989. ($1,300) 



Senetar JE, Murray MD (co-principal investigator), Kohler RB. A prospective, unblinded study of 

ceftriaxone one gram administered once daily in adult patients with pneumonia. $1,250 from Roche 

Laboratories, Inc., 1988. ($1,250) 

Murray MD (preceptor), Black C, Kohler RB. Fellowship in Antimicrobial Pharmacotherapy. $20,000 from 

Hoechst Pharmaceuticals, Inc., 1987. ($20,000) 

Brater DC, Hall S, Murray MD (co-investigator). Clinical pharmacology of NSAIDs in the elderly. 

$1,508,265 from the NIH, R01 AG07631,v1987. ($179,789) 

McNulty C, Murray MD (co-principal investigator). Administration of gentamicin to infants at low flow rates 

- a comparison of conventional and retrograde injection, $1500 from Abbott Laboratories and Syva 

Corporation, 1982. ($1,500) 

Carlstedt BC, Murray MD (co-principal investigator), Chalmers RK. Facilitating Doctor of Pharmacy 

student development through comprehensive specification of knowledge and skill expectations, $20,000 

from Smith Kline Beckman Corporation, 1983. ($20,000) 

PROFESSIONAL SERVICE 

Association Memberships 

1997 - present American Pharmaceutical Association 

1989 - present American Society for Clinical Pharmacology & Therapeutics 

1989 - present Drug Information Association 

1989 - present International Society for Pharmacoepidemiology (Fellow) 

1981 - present American College of Clinical Pharmacy 

1977 - present American Association of Colleges of Pharmacy 

1974 - present American Society of Hospital Pharmacists 

2010 American Medical Informatics Association 

2000 - 2008 Heart Failure Society of America 

2000 – 2004 Indiana Pharmacists Alliance 

1996 - 2008 International Society for Pharmacoeconomics and Outcomes Research 

1997 - 2008 Society for General Internal Medicine 

1994 - 1999 American Public Health Association 

1992 - 1997 American Society of Consultant Pharmacists 

1991 - 1995 Indiana College of Clinical Pharmacy 

1989 - 1995 Indiana/Cincinnati Discussion Group (Local AAPS Chapter) 

1977 - 1994 Indiana Society of Hospital Pharmacists 

Editorial Boards 

2010 – present Pharmacotherapy, Scientific Editor 

2003 – present American Journal of Geriatric Pharmacotherapy 

2006 – 2010 Pharmacotherapy, Editorial Board 

2005 – 2010 Agency for Healthcare Research & Quality, WebM&M Patient Safety Network 

2004 Therapeutics and Clinical Risk Management 

Reviewer of Professional Publications 

2007 - 2010 Annals of Internal Medicine 

2011 British Medical Journal Quality & Safety 

2010 Clinical Pharmacology & Therapeutics 

1997 - 2010 Diabetes Care 



2002 - 2010 Journal of the American Medical Association (JAMA) 

1992 - 2010 Medical Care 

2000- 2010 Pharmacoepidemiology & Drug Safety 

1997 - 2009 Drugs & Aging 

2009 Research in Social & Administrative Pharmacy (RSAP) 

2008 BMC Medical Informatics and Decision Making 

2008 BMJ Clinical Evidence 

2008 Journal of the American Pharmacists Association 

2004 - 2007 Journal of the Society of General Internal Medicine 

2000 - 2005 Clinical Pharmacology & Therapeutics 

2003 - 2004 The American Journal of Medicine 

2002 - 2004 British Medical Journal (BMJ) 

2000 - 2003 Journal of the American Geriatrics Society 

2002 - 2003 The Medical Letter 

1988 - 2002 American Journal of Heath-Systems Pharmacy (AJHP) 

1999 - 2002 American Journal of Managed Care 

1993 - 2002 Annals of Pharmacotherapy 

2002 - 2002 The Joint Commission Journal on Quality Improvement 

2001 - 2002 Journal of Clinical Oncology 

2000 - 2002 Pharmacoeconomics 

1999 - 2002 American Journal of Medical Sciences 

1998 - 1999 Journal of Epidemiology and Biostatistics 

1998 - 1999 Journal of the American Pharmaceutical Association 

1997 - 2003 Drug Safety 

1997 - 1998 Ambulatory Child Health 

1995 - 1999 Journal of Gerontology: Medical Sciences 

1994 - 1997 American Journal of Kidney Diseases 

1993 - 1994 Clinical Pharmacy (now AJHP) 

1992 - 1996 American Hospital Formulary Service, Drug Information 1992, 1993 

Grant Review, Study Sections, and Data Safety Monitoring Boards 

2011 PhRMA Foundation CER Award in Excellence Review Committee 

2010 Agency for Healthcare Research Quality, ARRA OS: Scalable distributed 

research networks for CER (R01) SEP Review, June 24, 2010. 

2009 – 2012 Collaboration Among Pharmacists and Physicians to Improve Outcomes Now 

(CAPTION), Data and Safety Monitoring Board, R01HL091841 

2009 Ministry of Health, Singapore, Health Services Research Competitive Research 

Grant Reviewer 

2008 Health Literacy Grantee Meeting, (R01 AG031718) Washington, DC, December 

15, 2008 

2008 Reviewer, NIH HSOD Study Section, ZRG1-HOP-E (03), September 2008. 

2007 Reviewer, USP 2007-2008 Fellowship Award Program 

2007 ZAG1 ZIJ-4 A1, Loan Repayment Reviewer for the National Institute on Aging. 

2001 – 2006 RFA HL-01-005, "Overcoming barriers to treatment adherence in minorities and 

persons living in poverty." Study Section. 

2000 – 2004 NIH RFA OD-00-006, "Testing Interventions to Improve Adherence to 

Pharmacological Treatment Programs." Study Section. 

2006 Beeson Career Development Awards, Review Panel, National Institute on Aging, 

March 2006. 

2005 Drug Name Suffixes and Medication Errors: Exploring the relationship and 

minimizing the risk. National Coordinating Council for Medication Error Reporting 

and Prevention, Chicago, October 20, 2005. 



2004 Data and Safety Monitoring Board, Take Care of Your Blood Pressure (TCYB) 

Study, Hayden Bosworth, PhD (principal investigator) 

2003 Reviewer, USP Expert Panel on Therapeutic Decision Making [Panel Report 

Evidence Methodology Workgroup], USP-AMCP Drug Interactions Project 

2003 Invited Expert on Quality & Safety, National Healthcare Information Infrastructure 

Conference, Washington, DC 

2003 USP Fellowship Review Committee 

2003 Chair, USP Expert Panel on Therapeutic Decision Making [Panel Report 

Evidence Methodology Workgroup], appointed 2001 

2002 Project Reviewer, University of Wisconsin-Milwaukee Institute of Environmental 

Health (IEH) 

2002 WebM&M Advisory Panel. Web-based Patient Safety Project sponsored by the 

Agency for Health Care Research and Quality, appointed 12/2001. 

2002 Data and Safety Monitoring Board, AIM Study, Linda Williams, MD (principal 

investigator) 

2001 Pharmacotherapy Self-Assessment Program, Fourth edition. American College 

of Clinical Pharmacy 

2001 Purdue University International Programs Grant Reviewer 

1998 Retrospective and Claims Data Studies Advisory Panel, International Society for 

Pharmacoeconomics and Outcomes Research 

1997 Planning Member, Breakthrough Series Collaborative on Improving Prescribing 

Practices, Institute for Healthcare Improvement, Boston, MA., 1997-1998 

1997 Interdisciplinary Peer Reviewer for Asthma Drug Treatment Protocols, American 

Pharmaceutical Association, 8/4/97 

1997 Policy Committee, American Pharmaceutical Association 

1996 Pharmacoeconomics Fellowship Selection Committee, American Society of 

Consultant Pharmacists 

1995 Continuity of Pharmaceutical Care, Request for Proposals from American Society 

of Consultant Pharmacists, American Society of Health-Systems Pharmacists, 

American Pharmaceutical Association 

COMMITTEE SERVICE 

National/International 

2011 Air Force Medical Service Health Services Data Warehouse Initiative Policy & 

Governance Committee 

2011 International Conference on Pharmacoepidemiology 2011 Scientific Program 

Committee 

2011 Planning Committee, Air Force Medical Service – Clinical and Translational 

Sciences Award Collaboration Symposium: Opportunities in Translational 

Science, Enabling New Research for Patient Centered Outcomes, Applied 

Informatics, and Pharmacoeconomics, May 13, 2011, National Institutes for 

Health Campus, Bethesda. 

2010 CTSA, Comparative Effectiveness Research Key Function Committee. 

2007 – present University of Pennsylvania NIGMS-funded training program Clinical 

Pharmacoepidemiology External Advisory Committee member 

2005 – 2010 Chair, Safe Medication Use Expert Panel, United States Pharmacopeia (USP), 

elected 3/2005, (2005-2010) 

2005 – 2010 Executive Committee, United States Pharmacopeia (USP) Council of Experts 

2005 – 2010 Ex officio, National Coordinating Council for Medication Error Reporting and 

Prevention 



2006 – 2008 Medication Safety Advisory Group, Joint Commission International Center for 

Patient Safety, appointed 7/19/2006-9/3/2008 

2007 Scientific Programs Committee for Social and Administrative Sciences Section 

Division (AACP) member. Reviewed abstracts for the 2007 AACP Annual 

Meeting 

2007 Mentored Investigator Development Program Advisory Board member (ACCP) 

2005 – 2006 Drug Safety Task Force of the American Society for Clinical Pharmacology & 

Therapeutics (ASCPT) 

2005 External Advisory Committee, Drug Safety Institute and Brand Institute 

2004 – 2005 Medicare Model Guideline Expert Committee, Medicare Prescription Drug 

Improvement and Modernization Act of 2003, United States Pharmacopeia 

(USP), appointed 4/16/04 

2004 – 2005 Scientific Committee, American Society for Clinical Pharmacology & 

Therapeutics (ASCPT) 

2004 Volwiler Research Achievement Award Committee, American Association of 

Colleges of Pharmacy 

2003 – 2004 ISPE Fellow Selection Committee 

2003 MedMARx Business Model Working Group, United States Pharmacopeia (USP) 

2003 American Society for Clinical Pharmacology & Therapeutics Co-chair CAR/PHE 

Symposium Improving Therapeutic Decision Making in the 21st Century, 4/4/03. 

2003 – 2005 International Society for Pharmacoepidemiology (ISPE) Fellow Selection 

Committee 

2002 - 2004 Annual Meeting Scientific Programs Committee, American Society for Clinical 

Pharmacology & Therapeutics 

2002 American Society for Clinical Pharmacology & Therapeutics, Educational 

Symposium Co-chair Symposium “Drug Interactions with Herbal Products & 

Food” 7/22/2002 & 7/23/2002 

2001 - 2003 Professional Affairs Committee, American Association of Colleges of Pharmacy, 

appointed 5/1/01 

2001 – 2005 Therapeutic Decision-Making Expert Committee, United States Pharmacopeia 

(USP), elected 4/19/01 (2001-2006) 

2000 – 2005 MedMARx Scientific Advisory Group, United States Pharmacopeia (USP), 

appointed 9/08/00 

2000 – 2005 Safe Medication Use Expert Committee, United States Pharmacopeia (USP), 

elected 6/30/00 (2000-2005) 

2000 - 2004 Board of Directors, American Society of Clinical Pharmacology & Therapeutics, 

appointed 3/01 

2000 - 2004 Chair, Committee on the Coordination of Scientific Sections, American Society of 

Clinical Pharmacology & Therapeutics, appointed 3/01 

1998 - 2001 Chairperson, Scientific Section on Pharmacoepidemiology, American Society for 

Clinical Pharmacology and Therapeutics, appointed 3/98 (1998-2001) 

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 

Advisory Panel on Conducting Evaluations using Retrospective and Claims Data 

1995 ISPE Publications Committee 

Scientific Programs, American Society for Clinical Pharmacology & Therapeutics 

1993 - 1994 ISPE Vision Committee 

ISPE Publications Committee 

Scientific Programs (Pharmacoepidemiology), American Society for Clinical 

Pharmacology and Therapeutics 

1991 – 2004 International Society for Pharmacoepidemiology (ISPE) Scientific Program 

Committee 

1991 - 1994 Board of Directors, International Society for Pharmacoepidemiology (ISPE) 

1991 - 1993 ISPE Chairman of Membership & Public Relations 



ISPE International Conference on Pharmacoepidemiology Planning Committee 

1990 - 1991 ISPE Co-chairman of Membership Committee 

ISPE International Conference on Pharmacoepidemiology Planning Committee 

Task Force on Curricular Issues, Section of Teachers of Pharmacy Practice 

American Association of Colleges of Pharmacy 

Scientific Programs (Pharmacoepidemiology), American Society for Clinical 

Pharmacology & Therapeutics 

1988 - 1990 ISPE International Conference on Pharmacoepidemiology Planning Committee 

1987 - 1989 Convenor, Seminars in Clinical Pharmacy, a quarterly gathering of clinical 

pharmacists in Central Indiana; now the Indiana College of Clinical Pharmacy 

(ICCP) 

1987 - 1988 Steering Committee International Conference on Pharmacoepidemiology 

ISPE Planning Committee 

1986 - 1987 Educational Affairs Committee 

American College of Clinical Pharmacy 

1984 - 1985 Ad Hoc Membership Subcommittee on Curricular Issues 

Ad Hoc Membership Subcommittee 

American Association of Colleges of Pharmacy 

1983 - 1984 Membership Committee, American College of Clinical Pharmacy 

State 

2008 – 2009 Mandatory Counseling Workgroup, North Carolina Board of Pharmacy 

2006 – 2008 North Carolina Institute of Medicine (NC IOM) Task Force on Health Literacy, 

appointed 05/2006 

The University of North Carolina at Chapel Hill 

2004 – 2010 Cecil G. Sheps Center Policy Board, appointed July 29, 2004 

2004 – 2010 Executive Committee, School of Pharmacy 

2005 – 2010 Center for Excellence in Chronic Disease Illness Advisory Board, appointed 


2007 – 2010 Program on Literacy and Health, Steering Committee, Cecil G. Sheps Center for 

Health Services Research, University of North Carolina at Chapel Hill, appointed 

12/2006 

2005 – 2008 Faculty Council, appointed April 20, 2005 – June 30, 2008 

2006 – 2007 Advisory Committee, Program on Health Outcomes, Department of Health Policy 

and Administration, School of Public Health, appointed January 2006 

2005 – 2007 Humana Distinguished Professorship in Health Informatics Search Committee, 

School of Public Health 

2004 – 2007 Curriculum Committee, School of Pharmacy 

2005 – 2006 Carolina Cost and Quality Initiative (CCQI) Oversight Committee 

Purdue University 

2003 - 2004 Superior Students Committee 

Purdue University School of Pharmacy 

2003 School Awards Committee 

2002 - 2003 Nominations Committee 

2001 - 2003 Grievance Committee 



1992 - 1993 Committee on the Use of Human Subjects for Research 

1985 - 1988 Committee on Censure and Dismissal Proceedings 

1978 - 1988 Clerkship Instructors Committee 



1978 - 1983 Pharm.D. Admissions and Standards Committee 

Indiana University School of Medicine 

2011 Internal Executive Board, Indiana Clinical and Translational Sciences Institute 

(CTSI) Community Health Engagement Program (CHEP) 

2010 Chair, Comparative Effectiveness Research Subcommittee, Indiana Clinical and 

Translational Sciences Institute (CTSI) 

2010 Indiana Clinic Research Committee 

2002 Research Database Task Force Advisory Committee (10/02) 

1991 Geriatrics/Gerontology Interdisciplinary Committee 

1989 Geriatrics/Gerontology Topics Committee 

Regenstrief Institute 

2003 Indiana Medicaid SWAT Team 

2002 Clinical Epidemiologist Search Committee (10/02) 

Wishard Memorial Hospital 

2000 - 2002 Wishard Research Committee 

1979 - 1988 Pharmacy and Therapeutics Committee 

1983 - 1986 Reserved Antibiotic Program 

1982 - 1986 Drug Use Review Coordinator 

VA Medical Center 

2006 – 2007 Durham VA Center for Health Services Research in Primary Care Steering 

Committee, appointed 10/2006 

1995 - 1998 Research & Development Committee (Human Subjects) 

Voluntary Geriatric Medication Counseling 

From June 1990 to November 1994 I voluntarily visited with 340 elderly persons in their homes or at the 

Indianapolis Senior Citizens Center, Indianapolis, Indiana to assist them with their medications or 

decisions about taking their medications. 

Other Community Service 

Vice-President Indiana State Soccer League (Director of State of Indiana Men's Division), 1996-97 

Commissioner to the Indiana State Soccer League for Saints F.C., 1996-97 

Boys (Indoor/Outdoor) Soccer Coach, 1986-97

Michael D. Murray, PharmD, MPH April 25, 2012 - Purdue University

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?